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I. BACKGROUND
Ae DEVELOPMENT OF MECKEL’S CARTILAGE
In the early stages of development, the chick face consists of a series of
primordial buds, swellings of mesenchyme enclosed in ectoderm. The upper
jaw is formed by five primordia, and the lower jaw is developed from the two
mandibular primordia.
The mesenchyme within the mandibular primordia is derived from
two groups of progenitor cells (reviewed by Hall, 1987). One group is the
mesenchyme derived from embryonic mesoderm, and the second group is
the mesenchyme derived from cranial neural crest (NC) cells and is referred
to as ectomesenchyme (reviewed by Hall, 1987; Noden, 1987). The NC cells
populating the mandibular arch originate from rhombomeres (R) R1, R2, and
the posterior mesencephalon (Le Livre and Le Douarin, 1975; Noden, 1975;
Lumsden et al., 1991). The mesencephalic and rhombencephalic NC cells start
migrating away from the neural tube at stage 8. These cells reach the
mandibular primordia around stage 14-15 (Tyler and Hall, 1977; Hall, 1987)
and give rise to bone, cartilage, fibrous connective tissue, smooth muscle, and
the dermis of the mandibular arch (reviewed by Hall, 1987; Le Douarin, 1982;
Noden, 1987). The mesodei’mally-derived mesenchymal cells will give rise to
the myogenic cells of facial muscles (Noden, 1983; Noden, 1987).
The formation of the mandibular skeleton starts with the condensation
of ectomesenchymal cells localized in the center of the mandible at stage
24/25. Previous in vitro studies have indicated that chondrogenic and
osteogenic differentiation of NC-derived craniofacial ectomesenchyme is
dependent upon prior interactions with embryonic epithelia (Thorogood et
al., 1986). These data indicated the importance of tissue interactions during
and after migration for subsequent skeletogenic differentiation of cranial NC
cells. These interactions are referred to as chondrogenic-promoting and
osteogenic-promoting interactions (Thorogood et al., 1986). Among these
interactions, those leading to the formation of mandibular cartilage and bone
are best characterized. The earliest interactions are the chondrogenic-
promoting interactions leading to the formation of Meckel’s cartilage
(Thorogood et al., 1986). These interactions have been shown to occur
between the migratory NC and the adjacent dorsal cranial ectoderm at stage
9/10 (Bee and Thorogood, 1980). Overt chondrogenesis occurs later at stage
25/26 (5 days of incubation) (Tyler and Hall, 1977; Hall, 1987). Initially, the
chick mandibular skeleton consists only of Meckel’s cartilage. Later, the six
ossification centers for the membranous bones of the developing mandible
form around Meckel’s cartilage.
Meckel’s cartilage is a central rod of cartilage that runs the length of the
developing mandible (Romanoff, 1960; Hall, 1987). This cartilage is derived
from mandibular ectomesenchyme, and is present in all vertebrate embryos
(Hall, 1987). Although present in all vertebrate embryos, the developmental
fate of this NC-derived cartilage is species-specific.
In mammals, Meckel’s cartilage is only a temporary structure which,
for the most part, disappears within the body of the mandible (Ten Cate, 1975;
Hall, 1983). In mammals, only a small portion of the chondrocytes,
chondrocytes in the most rostral portion and chondrocytes in the articulating
ends of Meckel’s cartilage, undergo endochondral ossification and participate
in the formation of mandibular and middle ear bones (Bhaskar et al., 1953).
The midportion of Meckel’s cartilage (the cartilage near the first molar region
or the ossification center for membranous bone) in mammals is thought to be
replaced, not by bone, but with fibrous tissue, and gives rise to the
sphenomandibular ligament (Bhaskar et al., 1953).
The mechanisms regulating the differences in the fates of mammalian
Meckel’s chondrocytes are not well understood. Two possibilities have been
proposed. One proposal suggests that the entire Meckel’s cartilage
hypertrophies and resorbs, and a group of stem cells originating from
surrounding tissues invades this region and gives rise to bone and fibrous
connective tissue (Richman and Diewert, 1988). The second hypothesis
suggests that, rather than cells in the surrounding tissues, chondrocytes
within the Meckel’s cartilage directly give rise to bone and other connective
tissue (Richman and Diewert, 1988). Richman and Diewert (1988) used
intraocular grafting techniques to examine the fate of rat Meckelian
chondrocytes from different regions. Whereas hypertrophy and
endochondral-type ossification in the Meckelian chondrocytes was observed
in the rostral and articulating processes, transformation of the chondrocytes
into fibroblasts was observed in the midportion (Richman and Diewert, 1988).
The study by Richman and Diewert (1988) demonstrated the direct
participation of rat Meckelian chondrocytes in the formation of bone and
connective tissue in the mandible.
Unlike mammals, in birds, Meckel’s cartilage is a permanent structure.
Except for the retro-articular process, which undergoes hypertrophy and
mineralization (Jacobson and Fell, 1941; Romanoff, 1960), the remainder of
this cartilaginous rod persists into adult life as a non-hypertrophic,
unmineralized, and unossified cartilage (Romanoff, 1960) that becomes
surrounded by intramembranous bones (Tyler and Hall, 1977; Hall, 1982, 1983,
1987).
Therefore, the midportion of Meckel’s cartilage in both mammals and
birds appears to lack the ability to undergo endochondral ossification and give
rise to osteoprogenitor cells. In mammals, this portion transforms to
fibroblasts and gives rise to the sphenomandibular ligament; in birds, this
portion persists as cartilage into adult life.
The mechanisms regulating the developmental fates of chondrocytes:
whether to remain permanently as cartilaginous tissues without further
maturation and hypertrophy, or to undergo hypertrophy and participate in
the endochondral ossification processes, or to transform into fibroblasts, are
not well understood. One possibility that has been considered is that the
different developmental fates are due to the intrinsic differences between
chondrocytes (Solursh et al., 1986; Castagnola et al., 1987). This hypothesis
suggests that permanent chondrocytes lack the intrinsic potential that is
present in other chondrocytes that are replaced by bone. The other possibility
considered is that the fates of chondrocytes are determined and regulated by
microenvironmental factors (Solursh et al., 1986; Castagnola et al., 1987).
B. CHONDROGENESIS
Cartilage is a specialized form of avascular connective tissue that is
largely composed of widely dispersed cells embedded in the extracellular
matrix (ECM) (reviewed by Reddi, 1994; Carrington and Reddi, 1991; Muir,
1995). Cartilage plays diverse roles in the body. It has a supporting role in
some organs, and provides the basis for low friction surfaces in articulating
joints (reviewed by Hall and Newman, 1991; Carrington and Reddi, 1991;
Reddi, 1994; Muir, 1995). In addition, cartilage acts as a precursor or template
for the subsequent growth of many long bones during embryogenesis and
skeletal repair (Hall and Newman, 1991).
During development, at the sites where cartilage will form, the
mesenchymal cells undergo condensation, and then differentiate into cells
called chondroblasts (Ham and Cormack, 1987; Reddi, 1994). The
chondroblasts then proliferate, and synthesize and secrete the
macromolecular constituents of the cartilage matrix. As they secrete the
matrix, they encase themselves within basket-like cavities called lacunae and
become chondrocytes (Ham and Cormack, 1987; Reddi, 1994). Therefore,
chondrocytes are isolated from one another and are encased in lacunae
within the matrix. Unlike bone, cartilage contains no blood vessels.
Therefore, chondrocytes are sustained by diffusion of nutrients and gases
through the porous matrix to and from the blood vessels that lie far away
(reviewed by Muir, 1995). A compact layer of collagenous connective tissue,
the perichondrium, surrounds most of the cartilage mass (Ham and Cormack,
1987). Cartilage, unlike bone, is able to grow by swelling. The cartilage
expands from within as the chondrocytes, isolated in their lacunae in the
matrix, divide to give rise to new chondrocytes, each of which then proceeds
to secrete more matrix (reviewed by Muir, 1995). Although during early
phases of chondrogenesis the primary function of the chondrocyte is to
produce cartilage matrix, after cessation of growth there is no detectable cell
division and matrix synthesis by these cells (reviewed by Muir, 1995).
Unlike the bone matrix, cartilage matrix is deformable, consisting of
high concentrations of collagen fibers, proteoglycan, and water (reviewed by
Upholt and Olson, 1991). It is the unique composition of the ECM that gives
cartilage a flexible structure and its unique physiological properties to
withstand compressive and shearing forces at various sites (Reddi, 1994).
The first step in chondrogenesis is the formation of transient cellular
condensations or prechondrogenic aggregates within the mesenchyme, or, in
the case of the head, within the neural crest derived mesenchyme (Ede, 1983;
Solursh, 1983; Hall and Miyake, 1992). This condensation stage is followed by
overt differentiation and secretion of the cartilage-specific ECM. The
prechondrogenic condensations, like the preosteogenic condensations, are the
earliest visible manifestations of skeletogenesis and determine the pattern of
skeletal tissue within the embryo (Hall and Miyake, 1992; Dunlop and Hall,
1995). These condensations represent skeletal primordia and were termed the
"membranous skeleton" of the embryo by Grtineberg (1963) to emphasize
their distinct and important roles in skeletogenesis (Ede, 1983). The
prechondrogenic condensations were first reported by Fell (1925), in her
studies with the developing chick limb bud. In fact, the prechondrogenic
condensations in the developing limb bud are the most extensively described
condensations (see reviews by Hall, 1978; Thorogood, 1983; Johnson, 1986;
Hall and Miyake, 1992). These studies together indicate that, unlike the
preosteogenic condensations (Dunlop and Hall, 1995), prechondrogenic
condensations precede cytodifferentiation (reviewed by Johnson, 1986; Hall
and Miyake, 1992). During the condensation stage, mesenchymal cells with
chondrogenic potential become juxtaposed to one another (Hall and Miyake,
1992). The formation of prechondrogenic condensations has been shown to be
the result of cell aggregation, rather than differential mitosis (Thorogood and
Hinchliffe, 1975). After the initiation of condensations, there are increases in
cell density, cell-cell interactions, and the number of gap junctions (Coelho
and Kosher, 1991; Hall and Miyake, 1992). It is thought that the process of
condensation is a prerequisite for overt chondrogenesis. Cartilage first
differentiates in the centers of these condensations of mesenchymal cells.
Then, the adjacent cells progressively differentiate (Solursh, 1983). This
suggests a role for cell-cell interactions in the process of chondrogenesis. This
idea has been supported by in vitro studies, where, in the absence of signaling
molecules, conditions that allow close association of cells have been shown to
favor chondrogenesis (Caplan, 1970; Karasawa et al., 1979). Umansky’s 1966
study showed that dissociated limb mesenchymal cells differentiate into
groups of cartilage cells when cultured at densities greater then confluency. In
experiments with avian limb mesenchyme, aggregates of mesenchymal cells
containing extensive mulfilayering were observed. Cartilage matrix was
detected within the matrix by 36 hours. The forming cartilage rapidly
enlarged as adjacent mesenchyme cells were assimilated (Ahrens et al., 1977,
1979).
Chondrogenesis is marked by the appearance of cartilage-specific
extracellular molecules (Poole et al., 1989). Over six different types of collagen
have been identified in cartilage (reviewed by Prockop and Kivirikko, 1995).
Among these, type II collagen is the major collagenous component of the
cartilage ECM, and accounts for 95% of the total collagen in cartilage
(Mendler et al., 1989). The single copy gene that encodes the type II
procollagen chain, like genes encoding other fibrillar collagens, is very large
(about 30-40 kb) and contains 54 exons (reviewed by Upholt and Olsen, 1991).
More recent immunocytochemical and in situ hybridization analyses
indicated that, although type II collagen is the major collagen species of
cartilage, it’s presence is not limited to cartilage (Upholt and Olsen, 1991). For
example, type II collagen is also found in the vitreous of the eye, the nucleus
pulposus of intervertebral discs (Upholt and Olsen, 1991), the primary corneal
stroma in the chick (vonder Mark et al., 1977), several embryonic epithelia
(Kosher and Solursh, 1989; Thorogood et al., 1986), and developing chick and
mouse calvaria (Lovell-Badge et al., 1987; Kravis and Upholt, 1985).
Type II collagen is composed of three identical polypeptide subunits,
named a l(II) chains (Bornstein and Sage, 1980). The protein and gene
structure of the cl(II) polypeptide is similar to polypeptides of other fibrillar
collagens, indicating their relation to a single ancestral gene (reviewed by Hay,
1991). Collagen polypeptide chains are secreted as larger precursors of about
1000 amino acids called procollagens or pro c-chains (reviewed by Upholt and
Olsen, 1991; Prockop and Kivirikko, 1995). The procollagen chain contains
extra amino acids at both the NH2 and COOH terminus called propeptides,
that will later be removed extracellularly by N- and C-proteinases (Hay, 1991).
Previous studies indicated the presence of low levels of type II collagen
in young undifferentiated mesenchyme in the developing chick limb and
mandible (Kosher et al., 1986; Mina et al., 1991; Upholt and Olsen, 1991).
However, there were approximately 100 fold increases in the levels of type II
collagen mRNA as condensation occurred in limb mesenchymal cells in vivo
(Kravis and Upholt, 1985). With further differentiation, there were
additional increases in the levels of type II collagen expression in the
developing limb and mandible (Kosher et al., 1986; Mina et al., 1991; Upholt
and Olsen, 1991).
Therefore, the formation of prechondrogenic aggregates is not
associated with the initiation but with the enhancement of transcription of
the type II collagen gene. The increases in the levels of type II collagen
expression, the major collagen species of cartilage, correlate with the
appearance of a histologically-detectable cartilage matrix, initiation of
synthesis of chondroitin sulfate, and stabilization of the cartilage phenotype
(Linsenmayer et al., 1973). Okayama (1976) also noted that type II collagen
chains were first detected when definitive chondroblasts could be observed
microscopically.
The more detailed characterization of the 5’-end of the human, rat
(Ryan and Sandell, 1990; Ran et al., 1990), and chick (Nah and Upholt, 1991)
type II collagen gene have revealed the existence of two forms of type II
collagen mRNA in the developing tissues. The two forms, type IIA and type
IIB, have been shown to be the result of alternative splicing in exon 2 (Ryan
and Sandell, 1990; Ryan et al., 1990; Nah and Upholt, 1991). The alternatively
spliced domain in exon 2 encodes a 69 amino acid cysteine-rich region of the
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NH2 propeptide (Ryan and Sandell, 1990; Nah and Upholt, 1991). These two
splice forms are differentially expressed by distinct cell populations during
embryogenesis (reviewed by Muir, 1995). Whereas type IIA, containing the
exon 2, is expressed in prechondrogenic cells, the type IIB, the type without
the second exon, is expressed primarily when cartilage has formed, and is the
predominant form in differentiated cartilaginous tissues (Ryan and Sandell,
1990; Sandell et al., 1991, 1994; Nah and Upholt, 1991). In addition, the
expression of type IIA in non-cartilaginous tissues, including calvaria, skin,
heart, and skeletal muscles, has been reported (Sandell et al., 1994; Nah and
Upholt, 1991). The expression of type IIA procollagen in pre-cartilaginous
structures and the restricted expression of type IIB procollagen by
chondrocytes implies that a change in splice form may be necessary for
chondrogenesis to occur (Reviewed by Muir, 1995).
The weight bearing property of cartilage is mainly due to the large
amount of aggrecan, a cartilage-specific proteoglycan, present in the ECM
(reviewed by Muir, 1995; Hassell et al., 1986; Hardingham et al., 1994;
Hardingham and Fosang, 1992). Aggregan, one of the major components of
the cartilage ECM, belongs to the proteoglycan family of molecules (reviewed
by Hassell et al., 1986). Aggrecan monomers, like other proteoglycan
monomers, typically consist of highly sulfated and negatively charged
glycosaminoglycan (GAG) side chains, that are covalently linked at serine
residues to a core protein (reviewed by Hay, 1991). The core protein in
cartilage aggrecan is a serine-rich protein with more than 2000 amino acids
where approximately 100 chondroitin sulfate and 30-50 keratin sulfate side
chains (1 glycosaminoglycan chain for every 20 amino acids residues) are
added post-translationally (Hay, 1991).
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In spite of intense studies of aggrecan, the characterization of the core
protein of the cartilage aggrecan has been hampered until recently, due to the
combination of the large amount of complex carbohydrate (80-90% of the total
mass), the variations in the amount and size of the side chains, and the
relatively large size of the core protein. However, discovery of substrate-
specific polysaccharides and advances in molecular biology techniques for
sequencing the core protein cDNA have allowed a more detailed
understanding of the molecular structure of the core protein. It is now
known that aggrecan core protein has an apparent molecular weight of
340,000, and is encoded by a single highly conserved gene of about 50 kb with
at least 15 exons (Doege et al., 1990) residing on chromosome 15 (Korenberg et
al., 1993). The deduced primary amino acid sequence of aggrecan core protein
in various species together with the rotary shadowing electron microscopy
indicated that aggrecan core protein possesses five domains, including three
globular domains and two linear inter-globular regions (Doege et al., 1986a,
1990, 1987). The two connected globular domains, G1 and G2, are found in the
N-terminus. The third globular domain, G3, is found near the C-terminus
(reviewed by Hay, 1991; Muir, 1995). The large inter-globular domain (of
about 260 nm, and 108 amino acids), that separates the G2 domain from the
G3 domain, is the major site for GAG side chain attachment (reviewed by
Hay, 1991; Hardingham and Fosang, 1992; Halberg et al., 1988). The GAG
chains, chondroitin sulfate (20-30 kd), keratin sulfate (10-15 kd), and O-linked
oligosaccharides are closely spaced in this region (Hassell et al., 1986). In
aggrecan isolated from bovine and human cartilage, but not rat cartilage,
there is an additional stretch of 108 amino acids (reviewed by Oldberg et al.,
1990; Upholt and Olson, 1991). This region consists of a highly conserved
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hexamer peptide motif repeated 23 times, where keratin sulfate side chains
are tightly attached (Oldberg et al., 1990). The short inter-globular segment of
about 21 nm that separates the G1 from the G2 domain has attracted
considerable interest, as it may provide the site for proteolytic cleavage on
aggrecan core protein during extracellular turnover and matrix degradation
(Sandy et al., 1991).
The G1 and G2 domains are structurally homologous with each other
and contain tandemly repeated double loops (reviewed by Oldberg et al., 1990;
Upholt and Olson, 1991). However, whereas the G1 domain does interact
with hyaluronic acid (HA) and the link protein (see below), the G2 domain
lacks the HA- binding ability (Hay, 1991). The binding of the G1 domain to
HA is mediated by immunoglobulin (Ig)-fold that is not present in the G2
domain (Hardingham and Fosang, 1992). The function of the G2 domain is
unknown. The amino acid sequence of the G3 domain, although unrelated
to the G1 and G2 domains, is homologous to other regulatory protein families
(Halberg et al., 1988).
Rotary shadowing electron microscopy indicated that, in addition to
aggrecan monomers, the cartilage ECM also contains huge multi-molecular
aggrecan aggregates (revieved by Ruoslahti, 1988; Hassell et al., 1986; Kimura
et al., 1979). Most of the cartilage proteoglycan aggrecan is present in the
aggregate form. These aggregates consist of about 100 aggrecan monomers,
each of about 2- 3 x 106 daltons, that are laterally arranged along the length of
a HA molecule (Sandy et al., 1989). Such aggregates have a molecular weight
of 108 or more and occupy a volume equivalent to that of a bacterium
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(reviewed by Muir, 1995). The aggregate resembles a bottle brush with an
equivalent number of bristles. As described above, each bristle consists of a
core protein with laterally projected GAG side chains. Each aggrecan
monomer is non-covalently bound through the G1 domain in the N-
terminus of the core protein to the single HA chain (Sandy et al., 1989;
Niedeusznski et al., 1980). The non-covalent bond between the core protein
and HA chain is further stabilized by interactions with the link protein
(Hardingham, 1979; Doege et al., 1986b). The link protein is a relatively small
proteoglycan (40 kd) that is structurally homologous to the G1 and G2
globular domains of the core protein (Doege et al., 1986b; Hardingham, 1979;
Hering et al., 1995). Similar to the G1 domain of the core protein, the link
protein contains a hyaluronic acid binding site (Hering et al., 1995). The
interaction of the link protein with HA is mediated by immunoglobulin (Ig)-
fold (Hardingham and Fosang, 1992). The presence of sulfated groups along
the entire length of each GAG chain of cartilage aggrecan creates a fixed
negative charge within the cartilage ECM network. Mutual electrostatic
repulsion between such like charges expands the aggregated molecule to its
maximal volume. In addition, these fixed negative charges entrap positively
charged molecules such as water (Hay, 1991). This arrangement ensures the
retention of a substantial volume of interstitial fluid and provides the
resilience in the cartilage matrix (reviewed by Muir, 1995; Hay, 1991). This
allows the cartilage to withstand compressive loads with minimal
deformities (reviewed by Muir, 1995).
Studies on the expression of the core protein of aggrecan during
chondrogenesis in vivo and in vitro indicated that, unlike type II collagen,
the expression of core protein is not detected prior to condensation. Core
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protein expression occurred concomitantly with condensation and increased
thereafter (reviewed by Upholt and Olsen, 1991). These studies indicate that
while condensation enhances the expression of type II collagen, it is associated
with the initiation of synthesis of aggrecan core protein mRNA.
G ENDOCHONDRAL OSSIFICATION
Endochondral ossification is a form of skeletogenesis in which cartilage
is replaced by bone. Endochondral ossification normally occurs during the
growth of long bones and in bone regeneration in fracture healing.
Chondrocytes undergoing endochondral ossification progress through an
orderly sequence of morphological and biochemical changes including
proliferation, hypertrophy, and mineralization. The calcified cartilage
provides the framework for the deposition of the bone (Ali, 1983).
The sequence of events involved during in vivo endochondral
ossification is most clearly illustrated in the growth plate of developing long
bones, where cells in various stages of development are organized in defined
zones. When observed in longitudinal sections, the epiphyseal plate exhibits
four morphologically distinct zones (Poole, 1991). From the epiphysis to
diaphysis, they are termed the zones of 1) resting cartilage, 2) proliferative
cartilage, 3) maturing and hypertrophic cartilage, and 4) calcifying cartilage.
The zone of resting cartilage is the zone nearest to the bone in the
epiphysis. Chondrocytes in the resting zone are small, flat cells which
undergo little or no cell division (Kember, 1960) and exhibit low metabolic
activity (Stocum et al., 1979).
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The resting cells enter a proliferative phase during which they divide
rapidly and change in shape from flat to discoid. Therefore, the zone of
proliferating cartilage contains actively proliferating and dividing
chondroblasts that supply new chondrocytes to replace those that disappear
from the diaphyseal end of the plate (Poole, 1991). In the proliferative zone,
cells divide and give rise to long columns of flattened cells (Poole, 1991). This
zone is morphologically characterized by longitudinal or parallel columns of
dividing chondrocytes. Chondroblasts in this zone synthesize and secrete a
hyaline ECM containing cartilage-specific proteoglycans (large keratin
sulfate/chondroitin sulfate proteoglycans) and collagens (type II,IX,XI)
(Oettinger and Pacifici, 1990). The deposition of the chondral matrix around
the chondrocytes results in further separation of these cells from neighboring
cells (Poole, 1991).
After active proliferation, the chondrocytes develop into large, round
hypertrophic cells that enter the zone of maturation and hypertrophy (Poole,
1991). The zone of maturing, hypertrophic cartilage contains chondrocytes
that are still arranged in nearly parallel columns. In addition, this zone is
characterized by increases in the cellular volume of individual chondrocytes.
The hypertrophic cells enlarge five to ten times in size and accumulate
glycogen and lipid (Buckwilter et al., 1986; Hunziker et al., 1987).
The ECM surrounding the hypertrophic chondrocytes then undergoes
mineralization. The zone of calcifying cartilage is the zone where the
cartilage matrix becomes heavily assimilated with bone minerals.
Calcification begins in discrete focal sites and eventually spreads throughout
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the cartilage matrix (Poole, 1991). The calcified cartilage is then invaded by
blood vessels and osteogenic cells. The cartilage is resorbed and eventually
replaced by bone.
In addition to the described morphological changes, endochondral
ossification is also characterized by an orderly sequence of biochemical
changes, including changes in the composition of the ECM molecules
(Reginato et al., 1986). The hypertrophic chondrocytes express a number of
ECM matrix proteins that are either absent or secreted in minimum amounts
during earlier stages of development. These biochemical changes include the
initiation of type X collagen synthesis (Gibson et al., 1982; Schmid and Conrad,
1982a; Schmid and Linsenmayer, 1987), and increases in levels of alkaline
phosphatase (Fell and Robison, 1934, 1929; Ali et al., 1970). The initiation of
Type X collagen synthesis and increases in alkaline phosphatase levels are
accompanied by decreases in the levels of synthesis for ECM molecules
characteristic of non-or pre-hypertrophic chondrocytes. The qualitative and
quantitative changes of the ECM are thought to facilitate subsequent
mineralization of the matrix.
lo Alkaline phosphatase
Alkaline phosphatae (APase) is an enzyme that releases inorganic
phosphate from organic substrates, or from inorganic substrates such as
pyrophosphate (Poole, 1991). This liberated inorganic phosphate can then
react with calcium to form the mineral hydroxyapatite, a form of calcium
phosphate (Poole et al., 1989). A high level of APase activity is believed to be
necessary in order to liberate enough phosphate to form mineral in the
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calcification process (Poole, 1991) Another possible additional role of APase is
the removal of pyrophosphate which is inhibitory to the formation of
calcium phosphate (Russell and Fleisch, 1976). APase deficiency causes
hypophosphatasia, a condition characterized by a lack of mineralization of
cartilage and bone (Fraser, 1957; Ornoy et al., 1985).
Early studies by Robison (1923) and Fell and Robison (1929, 1930)
demonstrated a close correlation between APase content and mineralization.
Histochemical studies by Viininen (1980) and de Bernard et al. (1986) showed
a significant increase in APase activity in hypertrophic cells. Biochemical
analyses also showed that APase activity increases as cells progress from the
proliferative zone up through the hypertrophic zone (Kuhlman and
McNamee, 1970).
Studies have shown the primary location of APase to be the plasma
membranes of growth plate chondrocytes and in matrix vesicles (Ali et al.,
1970; Matsuzawa and Anderson, 1971; Viininen and Korhonen, 1979; Hsu et
al., 1985; de Bernard et al., 1986). Calcification of cartilage usually starts in
close association with these membrane-bound vesicles scattered in the matrix
(Anderson, 1969; Majeska and Wuthier, 1975; Wuthier, 1982). Matrix vesicles
contain large amounts of APase as well as pyrophosphatase, ATPase, AMPase,
and other enzymes that play a role in the mineralization process (Ali and
Evans, 1973; Matsuzawa and Anderson, 1971).
The association of increased levels of APase activity with
mineralization makes APase a useful marker for mineralization.
18
Type X collagen.
Type X collagen was discovered independently in the early 1980’s in
two different laboratories. Gibson et al. (1981, 1982) reported the identification
and partial characterization of a short-chain, triple helical collagen, named
"G" collagen from cultured chick embryonic sternal chondrocytes. Gibson et
al. (1981, 1982) reported that G collagen was produced only in trace amounts
by chick sternal chondrocytes grown on plastic dishes. However, when the
cells were cultured in collagen gels, this low molecular weight collagen was
produced in high amounts. The G collagen was shown to be composed of
three identical chains (Gibson et al., 1981, 1982). The molecular weight of each
Chain was estimated to be 59,000 (Gibson et al., 1981, 1982). Pepsin digestion
resulted in a product with a molecular weight of 45,000, indicating the
presence of non-collagenous domains in the G collagen. CNBr peptide
analysis showed that this collagen was distinct from the other known
collagens produced by cartilaginous tissues.
At the same time, the isolation of a new collagen, named "59K"
collagen, was reported by Schmid and Conrad (1982a). The 59K collagen was
isolated from the media of cultured tibial chondrocytes from chick embryos
(Schmid and Conrad, 1982a). The 59K collagen was also a low molecular
weight collagen, composed of three identical chains with molecular weights
of 59,000 (Schmid and Conrad, 1982a). Cyanogen bromide digestion of 59K
collagen yielded digestion products different from those of type II collagen or
other collagen chains synthesized by chondrocytes (Schmid and Conrad,
1982a). Schmid and Conrad (1982a) concluded that 59K collagen was a new
type of collagen, structurally distinct from the collagen types observed
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previously in chondrocytes, and composed 15-20% of the collagens in the
culture medium. Later, "G" collagen and "59K" collagen were determined to
be the same molecule, which was classified as "Type X" collagen (Schmid and
Linsenmayer, 1985a).
Subsequent biochemical and structural analyses of the type X collagen
molecule indicated that type X collagen molecules are homo-trimers [o(X)3] of
p01ypeptide subunits [c1 (X)]. The c1 (X) has an apparent molecular size of 59
KD on SDS-Page (Schmid and Linsenmayer, 1983; Schmid et al., 1986). The
molecular weight of each subunit is only half of the molecular weight of
fibrillar collagens (reviewed by Upholt and Olsen, 1991). Each polypeptide
chain of type X collagen contains three distinct domains. The smallest is a
short (52 amino acids) non-triple-helical domain at the amino-terminus. The
largest domain is a single triple-helical domain (460 amino acids, 138 nm rod).
The third is the globular, non-triple-helical domain at the carboxyl-terminus
that contains 162 amino acids (Ninomiya et al., 1986; Yamaguchi et al., 1989).
The non-triple-helical domain at the carboxyl-terminus of type X collagen,
unlike other collagens, is not removed by proteolytic cleavage; and it is
thought to be a part of the deposited intact type X collagen in vivo. The amino
acid composition of type X collagen is different from other known collagens.
Type X collagen was shown to have a high methionine content, low level of
arginine, and a lack of cystine (Schmid and Linsenmayer, 1983).
The isolation and characterization of chick type X collagen cDNA
(Ninomiya et al., 1986) and genomic clones (Ninomiya et al., 1990)
demonstrated fundamental differences in the structure of the type X collagen
gene from the other collagen genes. One of the unique characteristics of the
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type X collagen gene is its relatively small size. Unlike other collagen genes,
the type X collagen gene is only about 5kb. In addition, unlike other collagen
genes that contain a large number of exons (Fibrillar collagen genes contain
more than 50 exons, and type IX collagen genes contain over 30 exons), the
type X collagen gene contains only 3 exons. Exon 1 of about 97 bp encodes the
5’-untranslated sequences of the al(X). Exon 2, 159 nucleotides in length,
codes for most, but not all, of the amino-terminal non-triple-helical domain,
and the signal peptide of the 01(X). The large exon 3 of 2137 nucleotides codes
for the rest of the amino-terminal non-triple-helical domain, all of the triple-
helical domain, and all of the non-triple-helical domain in the carboxy-
terminal. Therefore, the triple-helical domain of c1(X) collagen is coded for
by one large exon, exon 3. However, the triple-helical domains of the fibrillar
collagens (types I, II, III, V and XI), and fibril-associated collagens (types IX and
XII) are encoded for by multiple small exons (Upholt and Olsen, 1991).
Biochemical (Schmid and Linsenmayer, 1983; Gibson and Flint, 1985;
Grant et al., 1985) and tissue distribution studies (Schmid and Linsenmayer,
1985a, 1985b; Linsenmayer et al., 1986) demonstrated that the synthesis and
expression of type X collagen is restricted to hypertrophic chondrocytes and
calcifying cartilage in cartilages undergoing endochondral ossification.
Schmid and Conrad (1982b) showed the restricted synthesis of H3-
proline labeled type X collagen protein by chondrocytes in the hypertrophic
zone of cartilage in vitro. Cartilage segments from different zones of the
chick tibiotarsus were cut into small pieces and incubated with L-H3 proline.
Twenty-four hours later, the tissue pieces were removed from the culture
medium. Type X collagen was only synthesized by the cartilage from the
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hypertrophic zone. This suggested that type X collagen was a marker for the
final stage of chondrocyte maturation.
The association of type X collagen with chondrocyte hypertrophy was
further strengthened by Gibson et al. (1984) using the chick sternum.
Using polyacrylamide gel electrophoresis of radiolabeled proteins,
Gibson et al. (1984) demonstrated that the synthesis of type X collagen in vitro
is restricted to hypertrophic chondrocytes isolated from the cephalic region of
the 18 day old embryonic chick sternum. In the 18 day old embryonic
sternum, the cephalic half of sternum contains enlarged hypertrophic
chondrocytes that are separated by large areas of ECM matrix. However, the
caudal portion contains smaller, closely packed cells that do not undergo
hypertrophy and remain cartilaginous into maturity. The results of the study
by Gibson et al. (1984) showed that whereas cells from both the cephalic and
caudal regions synthesized type II collagen and type XI collagens, only
chondrocytes from the cephalic region synthesized type X collagen. After
seven days of culture within collagen gels, 65% of the total collagen
synthesized by the cephalic chondrocytes was shown to be type X collagen
(Gibson et al., 1984). Their results indicated that type X collagen is specifically
synthesized by hypertrophic chondrocytes, and is not produced by the smaller
chondrocytes isolated from the permanent cartilaginous zone.
This work was later supported by Reginato et al. (1986) who looked at
the cephalic and caudal regions of the chick sternum at various stages of
development. They found that type X collagen increased with increasing age,
and was accompanied by a relative decrease in type II and type IX collagen.
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The expression of type X collagen was coincident with the development of
sternal calcification, and the permanent cartilage (caudal portion) did not
display detectable synthesis of type X collagen at any age.
Immunocytochemical studies by Schmid and Linsenmayer (1985a)
demonstrated the localization of type X collagen. The localization of type X
collagen was achieved using antibodies against type X collagen. Indirect
immunofluorescence analyses of skeletal and non-skeletal chick tissues were
performed using a monoclonal antibody specific for type X collagen. In
cartilage, reaction with this antibody was restricted to the hypertrophic zone.
The antibody did not react with cartilages of the trachea and sclera which do
not undergo hypertrophy during the stages examined. Only tissues of skeletal
origin showed detectable reactivity. No reactivity was found in any of the
non-skeletal tissues examined.
Further studies by Schmid and Linsenmayer (1985b) examined the
temporal and spatial distribution of type X collagen in the chick tibiotarsus
from the 6 day embryo to one day post-hatching. Type X collagen was first
detected at 7.5 days and was restricted to the primary center of ossification.
With increasing age, reactivity with the type X antibody progressively
extended toward the epiphyses, following the progression of chondrocyte
hypertrophy. Their results suggested that type X is specifically a product of
chondrocytes which have undergone hypertrophy.
Gibson et al. (1986), using antibodies against type X collagen,
demonstrated the specific association of type X collagen with regions of
hypertrophic chondrocytes in the embryonic chick sternum, embryonic
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tubular bone, and growth plate cartilages.
Leboy et al. (1988) examined gene expression in mineralizing chick
epiphyseal cartilage, measuring mRNA levels of type I,II, and X collagen.
Type II collagen was present in proliferating cartilage, and present in lower
levels in hypertrophic and calcifying cartilage. Type X collagen was absent in
proliferating cartilage, and present in hypertrophic and calcifying cartilage. In
endochondral bone, type I was the major species of collagen present, although
significant amounts of type X collagen was found.
Castagnola et al. (1988) measured the rate of transcription of the genes
encoding type I, II, IX, and X collagen and quantitatively measured the
amount of the mRNA for each collagen type. Using chick tibial chondrocytes
grown in suspension culture, they found a shift from type I to types II and IX
collagen when chondrogenesis began, and a shift from types II and IX collagen
to type X collagen when chondrocytes became hypertrophic.
Type X collagen has shown to be synthesized only in the maturing and
hypertrophic zones, and has not been found in cartilages which are not
committed to calcification. For this reason, type X collagen has been used as a
marker of cellular hypertrophy and endochondral ossification.
The appearance of type X collagen in the hypertrophic zone preceding
cartilage calcification has implied that type X collagen may have some role in
the calcification process, although the nature of this role has not been
elucidated.
24
One possible function is the facilitation of cartilage removal during
endochondral ossification. The theory that type X collagen may facilitate the
degradation of the ECM in which it is deposited was supported by Schmid et
al.’s (1986) finding that type X collagen contains two cleavage sites within its
triple helical domain for a vertebrate collagenase, whereas type II collagen has
only a single site.
The similar structure of type X collagen and type VIII collagen suggests
that they may have a similar function as well. Type VIII collagen is a main
component of the hexagonal lattice structure of Descemet’s membrane
(Sawada, 1982; Sawada et al., 1984). This structure resists compression while
maintaining an open, porous structure. Type X collagen may also function as
a scaffold to prevent the collapse of the cartilage matrix as the proteoglycans
and type II-containing fibrils are being broken down. Schmid et al.’s (1986)
finding that type X collagen has a relatively high thermal stability with a TM of
47’C supports the idea of type X collagen as a stable, supportive structural
element.
CHONDROCYTE HYPERTROPHY IN VITRO
lo In vitro hypertrophy of chondrocytes from normally hypertrophic
mesodermally-derivd cartilages
Previous studies have shown that the maturation process of
chondrocytes and associated changes in cell proliferation and phenotypic gene
expression can be reproduced in vitro.
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Adams et al. (1989, 1991) examined the behavior of immature vertebral
chondrocytes from 12-day old chick embryos in long term monolayer
cultures. Their results indicated that these initially small cells undergo rapid
proliferation in vitro. During the proliferative phase in vitro chondrocytes
synthesize predominantly type II collagen, type IX collagen and aggrecan core
protein. With time in culture, cells undergo hypertrophy, reduce their
proliferative activity, express type X collagen, and produce elevated levels of
APase. However, the study by Adams et al. (1991) showed that type X collagen
was only synthesized by a small fraction of vertebral chondrocytes in vitro. In
addition, the amount of type X collagen mRNA and protein synthesized by
vertebral chondrocytes after 29 days in culture was significantly lower than
the amount of type X collagen synthesized by mineralized cartilages in vivo.
(Adams et al., 1989, 1991).
However, the studies by Adams et al. (1989, 1991) and other studies
indicated that chondrocyte hypertrophy and the levels of type X collagen and
APase production by hypertrophic chondrocytes can be manipulated in vitro.
The role of cell shape on type X collagen synthesis, APase synthesis,
and other events associated with chondrocyte maturation has been
extensively studied.
A number of studies have demonstrated the roles of cell shape in
maturation-associated traits during chondrocyte hypertrophy. Elevated levels
of type X collagen mRNA and protein in chondrocytes cultured either in
suspension (Castagnola et al., 1986; Adams et al., 1989, 1991), or within
hydrated collagen gels (Gibson et al., 1982, 1984; Solursh et al., 1986), or agarose
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(Iwamato et al., 1989; Hunter et al., 1993), as compared to the levels of type X
collagen in chondrocytes grown in monolayer, have been reported. Adams et
al. (1991) reported that the amount of type X collagen mRNA and protein in
vertebral chondrocytes grown in suspension reached levels comparable to
that in mineralized cartilage in vivo.
These studies indicate that culture conditions that maintained or
promoted rounded cell morphology provide a favorable (permissive)
condition for hypertrophy and maturation of chondrocytes from normally
hypertrophic mesodermally-derived cartilages.
In addition to cell shape, several modifications of the media have been
found to induce chondrocyte hypertrophy in cultures. These include the
addition of retinoic acid (Oettinger and Pacifici, 1990; Pacifici et al., 1991),
addition of serum (Bruckner et al., 1989), replacement of serum by thyroxin
and insulin (Bohme et al., 1992; Quarto et al., 1992), and addition of ascorbic
acid (Leboy et al., 1989; Wu et al., 1989; Gerstenfeld and Landis, 1991).
Retinoic acid (RA), a derivative of vitamin A, has long been thought to
be involved in cartilage development. The possible involvement of RA in
the regulation of chondrocyte maturation and hypertrophy is implicated by a
number of in vitro studies.
Oettinger and Pacifici (1990) demonstrated a transient increase in the
levels of type X collagen mRNA and protein in chick vertebral chondrocytes
treated with 300 nM of all-trans-RA. Monolayer cultures of vertebral
chondrocytes isolated from day 12 embryos were exposed to exogenous RA.
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After 42 hours of exposure, there were significant decreases in the expression
of mRNAs .for type II collagen and aggrecan, but a three-fold increase in the
levels of type X collagen mRNA as compared to untreated cells. However,
after 72-120 hours of treatment, the levels of type X collagen mRNA decreased
and reached minimal levels. The study by Oettinger and Pacifici (1990)
suggested that RA may have a role in maturation and induction of type X
collagen gene expression.
Ascorbic acid (AA) is one of the factors that has been shown to enhance
chondrogenesis and promote hypertrophy and type X collagen expression in
mesodermally-derived chondrocytes from the cephalic region of the sternum
(Leboy et al., 1989), vertebrae (Gerstenfeld and Landis, 1991), and the growth
plate (Wu et al., 1989). It has been suggested that AA may play a role in
endochondral ossification.
Leboy et al. (1989) demonstrated increases in the levels of both type X
collagen mRNA and APase activity in AA-treated cultures from the cephalic
portion of 14-day chick embryo sternae compared to untreated cultures. In
this study, chondrocytes isolated from the cephalic portion of the sternum
were initially grown for 5 days in monolayer without the addition of
exogenous AA. After five days, floating chondrocytes were placed in
secondary cultures and received a gradually increasing dose of AA. 10 ug/ml
of AA was added after one day in secondary culture. The AA concentration
was increased to 25-50 ug/ml three days later. The cells were maintained for
11 days in secondary culture in the presence or absence of AA. There were
increases in the levels of type X collagen mRNA and APase activity in the
AA-treated cultures compared to the control untreated cultures. By nine days
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in secondary culture, the levels of both type X collagen mRNA and APase
activity in the AA-treated cells was 15-20 times higher than in the untreated
cells.
Shapiro et al. (1991) demonstrated the AA-mediated enhancement of
hypertrophy in chondrocytes isolated from 19-day old chick embryo tibia. In
this study, chondrocytes from tibial epiphyses were grown for 2 days in
primary culture and then transferred to secondary culture. AA was added
initially at a concentration of 10 ug/ml, and increased to 40 ug/ml on day 4 of
secondary culture. Cells were maintained for 19 days in secondary culture.
The control untreated chondrocytes showed very low APase activity. After 18
days in secondary culture, the AA-treated cells displayed APase activity three
times that of the untreated cells.
Although AA has been shown to enhance chondrocyte hypertrophy,
the exact mechanisms of action of this vitamin are not well understood. It is
thought that AA’s effects on chondrocyte hypertrophy may be mediated by its
effects on collagen biosynthesis. The essential role of AA in collagen
biosynthesis is well documented (Peterkofsky, 1972). AA promotes proline
and lysine hydroxylation, resulting in the formation of a more stable secreted
triple helical collagen (Kivirikko and Myllyla, 1987).
In vitro hypertrophy of chondrocytes from normally non-
hypertrophic (permanent) mesodermally-derived cartilages
The roles of the permissive culture conditions discussed above in the
regulation of chondrocyte hypertrophy and maturation have been examined
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and confirmed by studies using chondrocytes from permanent cartilages.
Similar permissive culture conditions have been shown to induce
hypertrophy in mesodermally-derived chondrocytes from permanent
cartilages which do not normally undergo hypertrophy in vivo. The two best
studied cartilages are chick articular cartilage (Iwamoto et al., 1989; Pacifici et
al., 1991a), and the caudal portion of the chick sternum (Solursh et al., 1986;
Castagnola et al., 1987; Pacifici et al., 1991b).
The caudal region of the sternum contains immature chondrocytes
that remain cartilaginous during post-natal life and undergo endochondral
ossification only in the adult animal (Gibson and Flint, 1985).
However, studies have shown that when grown in suspension
(Castagnola et al., 1987; Pacifici et al., 1991a), within collagen gels (Solursh et
al., 1986), or on agarose-coated dishes (Castagnola et al., 1987), these cells
proliferate, increase in average size, and, with time in culture, initiate type X
collagen synthesis.
Using similar permissive culture conditions, (conditions that influence
cell shape), it has been shown that articular cartilage, another permanent
cartilage, can also undergo hypertrophy in vitro. The induction of type X
collagen in long term suspension cultures of chicken tibial articular
chondrocytes was shown by Pacifici et al. (1991a).
In addition, it has been shown that RA can induce hypertrophy in
mesodermally-derived permanent cartilages. Pacifici et al. (1991b)
demonstrated the induction of type X collagen mRNA in cultured
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chondrocytes from the caudal region of the chick sternum. In addition to
induction of type X collagen, 3 days exposure of the cells to physiological doses
(10-35 nM) of retinoic acid resulted in increased APase activity.
These studies together show that mesodermally-derived permanent
cartilages have the intrinsic potential to express traits associated with
chondrocyte hypertrophy and maturation in response to favorable
microenvironments. These studies also suggest that the lack of chondrocyte
hypertrophy in vivo may be related to either the presence of inhibitory factors
or the absence of factors that promote maturation and hypertrophy.
Hypertrophy of Meckelian chondrocytes
There is a convincing body of literature indicating the ability of
chondrocytes from mesodermally-derived permanent cartilages to undergo
hypertrophy and maturation under in vitro permissive conditions.
However, there are conflicting data regarding the ability of the neural crest-
derived Meckelian chondrocytes to undergo hypertrophy and maturation in
vitro.
The recent study by Chung et al. (1995) demonstrated the expression of
type X collagen only in th articulating ends of rat Meckel’s cartilage in vivo.
Type X collagen expression was not detected in chondrocytes within the main
body of rat Meckel’s cartilage that does not undergo endochondral ossification
in vivo.
The study by Richman and Diewert (1988) on rat Meckel’s cartilage
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demonstrated that, unlike the chondrocytes in the rostral and articulating
processes, the chondrocytes in the midportion did not give rise to
osteoprogenitor cells, but transformed into fibroblasts. On the other hand, the
results reported by Ishizeki et al. (1990, 1992, 1994) indicate the potential of the
chondrocytes from the midportion of mouse Meckel’s cartilage to undergo
hypertrophy and calcification when transplanted into the spleen.
Similar to the reported studies in mammals, the fate, or the ability to
hypertrophy, of chick Meckelian chondrocytes is not clear.
Kavumpurath and Hall (1990) examined the effects of thyroxine on
organ-cultured chick Meckel’s cartilage from stage 34-39 embryos. Their
results indicated that exposure of fully differentiated Meckel’s cartilage to 7.5
nM thyroxine, a hormone that has been shown to promote chondrocyte
hypertrophy and maturation in other cartilages (Burch and Lebovitz, 1982),
failed to induce hypertrophy in chick Meckelian chondrocytes. However,
similar exposure of differentiated tibial chondrocytes to thyroxine did induce
hypertrophy and maturation in the tibial chondrocytes.
In addition, the tissue recombination studies by Kavumpurath and
Hall (1990) demonstrated the inability of chick mandibular epithelium from
stage 22 embryos to initiat osteogenesis in differentiated Meckel’s cartilage.
These observations (Kavumpurath and Hall, 1990) indicated the inability of
chick Meckelian chondrocytes to hypertrophy and give rise to osteoprogenitor
cells. On the other hand, Kavumpurath and Hall (1988) demonstrated the
ability of chick Meckelian chondrocytes to give rise to perichondrium-like
cells. Organ-cultured Meckel’s cartilage, stripped from its perichondrium,
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generated a new perichondrium around it (Kavumpurath and Hall, 1988).
However, more recent observations suggest that exogenous AA may
induce hypertrophy and maturation in Meckelian chondrocytes. Ekanayake
and Hall (1994) demonstrated the expression of type X collagen in 10-day
micromass cultures from stage 21 chick mandibular ectomesenchyme treated
with 150 ug/ml AA. APase histochemistry by Gluhak et al. (1996)
demonstrated the presence of hypertrophic chondrocytes in 13-21-day
micromass cultures from stage 23 chick mandibular ectomesenchyme treated
with 200 ug/ml of AA. Type X collagen expression (Ekanayake and Hall, 1994)
and APase staining (Gluhak et al., 1996) were not observed in control
untreated cultures. Furthermore, addition of dexamethasone to micromass
cultures of mandibular ectomesenchyme inhibited chondrogenesis and did
not induce hypertrophy (Ekanayake and Hall, 1994). These studies together
suggest that Meckelian chondrocytes, similar to articular chondrocytes, can
undergo hypertrophy in the presence of AA with time in culture.
E. SUMMARY
Most cartilages that appear during embryonic development undergo
endochondral ossification and are replaced by bone. However, there are a few
cartilages with developmehtal fates that appear to be different from other
cartilages in that they persist into adult life. Chondrocytes in the articulating
ends of the long bones, in the caudal half of the sternum, and in the tracheal
ring, are examples of mesodermally-derived permanent cartilages that persist
into adult life both in birds and mammals.
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Meckel’s cartilage is a neural crest-derived cartilage that is present in all
vertebrate embryos (Hall, 1987). Whereas in mammals it is only a temporary
structure which disappears within the body of the mandible (Ten Cate, 1975;
Hall, 1983), in birds, this structure for the most part persists into adult life
(Romanoff, 1960), and is therefore considered as one of the permanent
cartilages.
The mechanisms regulating developmental fates of chondrocytes:
whether to remain permanently as cartilaginous tissues without further
maturation and hypertrophy, or to undergo hypertrophy and participate in
the endochondral ossification processes, are not well understood. One
possibility that has been considered is that the different developmental fates
are due to the intrinsic differences between cartilages (Solursh et al., 1986;
Castagnola et al., 1987). This hypothesis suggests that permanent chondrocytes
lack the intrinsic potential that is present in other cartilages that are replaced
by bone. The other possibility considered is that the fates of chondrocytes are
determined and regulated by microenvironmental factors (Solursh et al.,
1986; Castagnola et al., 1987).
Most of the previous studies on chondrocyte hypertrophy and
maturation have used mesodermally-derived cartilages, such as the growth
plate in long bones and thee sternum. These studies have demonstrated the
ability of these mesodermally-derived permanent cartilages to undergo
hypertrophy and maturation in vitro (Solursh et al., 1986; Castagnola et al.,
1987; Pacifici et al., 1991a, 1991b). On the other hand, the results of the few
studies regarding the ability of ectodermally-derived Meckelian chondrocytes
to undergo hypertrophy and maturation are conflicting and inconclusive
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(Kavumpurath and Hall, 1990; Ekanayake and Hall, 1994; Gluhak et al., 1996).
II. HYPOTHESIS
Permanent chondrocytes from chick Meckelian cartilage can be induced
to hypertrophy in vitro.
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III. OBJECTIVES AND SPECIFIC AIMS
This study investigated whether the permanent chondrocytes from
chick Meckel’s cartilage could be induced to mature and undergo hypertrophy
when removed from their in v ivo environment and placed into a
permissive environment in vitro.
The specific aims of this study were to examine the possibility of
hypertrophy in Meckelian chondrocytes in vitro by examining the changes
over time in the" 1)cell morphology, 2) cell proliferation, 3) APase activity,
and 4) expression of type X collagen mRNA in Meckelian chondrocytes placed
in long term monolayer cultures with and without AA.
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IV. MATERIALS AND METHODS
A. Chondrocyte Culture. Meckel’s cartilage rods were isolated from the
mandibles of 12-day old chick embryos in Hank’s Balanced Salt Solution
(HBSS) containing 10% fetal calf serum. The perichondrium was removed
carefully under a dissecting scope. The rods of cartilage were incubated with
0.1% collagenase (type 1A, Sigma) and 0.25% trypsin (Sigma) in HBSS for one
hour at room temperature. After one hour, the enzyme solution was
discarded and the cartilaginous rods were incubated at 37C in a fresh mixture
of enzyme solution for an additional two hours. A cell suspension was
prepared by pipetting the tissue fragments vigorously through fire-polished
pipettes. The resulting cell suspension was recovered by centrifugation,
suspended in complete media containing high glucose DMEM (GIBCO BRL),
2 mM glutamine, 100 U/ml penicillin, 100ug/ml streptomycin, and 0.25
ug/ml fungizone (antibiotic/antimycotic), 10 ug/ml gentamicin (GIBCO BRL),
and 10% fetal calf serum, counted, and plated in primary cultures at a density
of 1.5-2.0x106 cells/60 mm tissue culture dish (Falcon). Previous studies had
demonstrated that after plating in primary cultures, the accumulation of the
matrix components around the periphery of the chondroblasts cause a
gradual detachment of the cells from the tissue culture plastic substrate and
induce them to become "floaters". This unusual property of the
chondroblasts was used to ensure their separation from the possible
contaminant fibroblasts which strongly adhere to the plastic substrate. Pure
populations of floating chondroblasts were harvested from the medium of 7
day old primary cultures by centrifugation and resuspended in complete
media and plated into secondary cultures at the same initial density (1.5-
2.0x106 cells/60 mm dish) (Costar). To increase cell adhesion, 4 units/ml of
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hyaluronidase (Sigma) were added to the medium of secondary cultures.
Cultures were fed every two days after plating with complete medium.
Secondary cultures were subcultured every seven days using a 0.1%
collagenase/0.25% trypsin enzyme solution, plated at the same initial density,
and maintained until day 21.
Cultures receiving AA" 10 ug/ml of AA (Sigma) was added after one
day in secondary culture. The AA concentration was increased to 25 ug/ml
three days later. Fresh AA was added to cultures daily (Leboy et al., 1989).
Alkaline phosphatase assay. At regular timepoints, a sample was taken
to be assayed for APase activity. These timepoints were: 1) one day in primary
culture, 2) seven days in primary culture, 3) seven days in secondary culture,
4) fourteen days in secondary culture, and 5) twenty-one days in secondary
culture. Approximately 1.5x106 cells were centrifuged at 5000 rev/min for 10
min, the supernatant was discarded, and the pellet was washed twice with
0.9% NaC1. The cells were then solubilized by a 30 min incubation in 1 ml of
assay buffer containing 0.15 M TrisHC1 (pH 9.0), 0.1 mM MgC12, 0.1 mM ZnC12,
and 1% Triton X-100. The cell lysate was centrifuged for 2-3 min and the clear
lysate (supernatant), containing the APase, was collected and stored at-70C.
Twenty ul of the soltbilized cell extract was assayed for APase activity.
The assay depends on the hydrolysis of p-nitrophenyl phosphate by APase,
yielding p-nitrophenol and inorganic phosphate. At a basic pH, p-
nitrophenol is converted to a yellow complex which can be measured at 400-
420 nm. The intensity of color formed is proportional to the phosphatase
activity. Dilutions of a p-nitrophenol standard solution (Sigma 104-1) were
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used to construct a calibration curve. One hundred and eighty ul of assay
mixture was added to 20 ul of the sample in microtiter plate wells. The assay
mixture was composed of 20 mg p-nitrophenyl phosphate (PNPP) (Sigma 104-
40), 43 ul MgC12 (1 mM), 1.08 ml AMP buffer (Sigma 221), and 9.72 ml water.
The microtiter plate was incubated at 37’C until color developed (up to 2
hours). Readings were made every 15 min at 410 nm. The samples were also
assayed for protein, and activity was calculated in umoles/min/mg.
Ten ul of the solubilized cell extract was assayed for protein using the
Bicinchoninic acid (BCA) protein assay (Pierce). BCA is highly specific for the
cuprous ion (Cu/). Protein reduces Cu2/ to Cu/ in an alkaline medium. Two
molecules of BCA react with one cuprous ion (Cu/) to form a purple reaction
product which can be measured at 562 nm, allowing the spectrophotometric
quantitation of protein.
Two hundred ul of reaction mixture were added to 10 ul of sample in
microtiter plate wells. The reaction mixture was composed of 1 part Reagent
B (a 4% copper sulfate solution) to 50 parts Reagent A (the base reagent,
containing sodium carbonate, sodium bicarbonate, BCA detection reagent,
and sodium tartrate in 0.2 N NaOH) (Pierce). Ten ul of various dilutions of a
protein standard were also combined with 200 ul of the reaction mixture to
construct the calibration curve. The microtiter plate was put in a 60C oven
for 30 min and read at 570 nm.
C. RNA Isolation. At the same timepoints listed under "IIIB. Alkaline
phosphatase assay", a sample was also taken for type X and aggrecan core
protein mRNA determination. Approximately 1.5x106 cells were centrifuged
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at 5000 rev/min for 10 min. The supernatant was discarded. Two and a half
ml of TRIzol Reagent (GIBCO BRL) were added to the pellet. The cells were
lysed in the TRIzol Reagent by repetitive pipetting. The samples were stored
at-70’C until ready for RNA isolation. The samples were then incubated for
5 min at room temperature. Two hundred ul of chloroform were added per 1
ml of TRIzol Reagent. The tubes were shaken by hand for 15 seconds and
incubated at room temperature for 2-3 min. The samples were centrifuged at
12000xg for 15 min at 4C. Centrifugation separated the mixture into a lower
red, phenol-chloroform phase, an interphase, and a clear upper aqueous
phase, containing the RNA. The RNA was precipitated from the aqueous
phase by mixing with 500 ul isopropanol per 1 ml of TRIzol reagent. The
samples were incubated at room temperature for 10 min and centrifuged at
12000xg for 10 min at 4C. The RNA pellet was washed with 70% ethanol and
reprecipitated. The concentration of RNA was determined
spectrophotometrically.
Recombinant DNA probes, The recombinant DNA clones used in
these studies were:
1) Type X collagen: Riboprobe was prepared from the 5’ end of chick cDNA
clone PYN3116 (Ninomiya et al., 1986). The 181 bp anti-sense Type X collagen
riboprobe was prepared br in vitro transcription of a 181 bp PCR-amplified
cDNA fragment (Ninomiya et al., 1986). The following oligonucleotide
amplification primers were used" 5’ primer, 5’-
CCCTGGTcTATAcTATTTCTC-3’ with the 5’ residue corresponding to
nucleotide 12; 3’ primer, 5’AGCTGGAGCCACAcTTG-3’ with the 3’ residue
corresponding to nucleotide 193. The 3’ oligonucleotide for the PCR reaction
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contained the 23 bp T7 RNA polymerase promoter sequence. The 181 bp anti-
sense type X collagen riboprobe was prepared by in vitro transcription of an
amplified fragment using T7 RNA polymerase (Stratagene).
2} Aggrecan core protein" The probe used for aggrecan core protein mRNA
was a 960 bp (SalI/KpnI) fragment of the chicken cDNA clone ST1 (Mallein-
Gerin et al., 1988).
3) Glyceraldehyde 3-phosphate dehydrogenase (GAPDH): The probe used for
GAPDH mRNA was a 1.3 kb (Eco RI/Eco RI) fragment of cDNA clone (Quail
and Yeoh, 1995).
The cDNA inserts were separated from plasmids by electrophoresis on
a 1% low melting temperature agarose gel. DNA probes were labeled with 32p
dCTP using the random oligonucleotide priming method of Feinberg and
Vogelstein (1983, 1984).
E. Northern blot hybridization, Ten ug of total RNA was denatured
with formamide-formaldehyde, separated by electrophoresis on a 1% agarose
gel, and transferred to a nylon membrane (Schleicher and Schuell, Inc.).
Membranes were pre-hybridized (overnight at 42C) and then hybridized
(overnight at 55C) with approximately 5x106 cpm of 32p-labeled-DNA probe
for aggrecan.
Following autoradiography, the Northern blot was reprobed with a 32p_
labeled GAPDH cDNA. Following autoradiography, the filters were reprobed
with 5x106 cpm 32p-labeled-RNA probe for type X collagen mRNA. The
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amount of the 1.3 kb GAPDH mRNA was used to normalize for the
variations in the amount of RNA loaded in each sample. The size of mRNA
was estimated by reference to RNA size markers (BRL) run in adjacent lanes.
For the aggrecan probe, the prehybridization solution contained 50%
formamide, 5X SSC, 10X Denhardt’s solution, 50 mM sodium phosphate
buffer (pH 6.0), 1% glycine, 100 ug/ml of denatured salmon sperm DNA, 200
ug/ml torula yeast RNA (5 prime- 3 prime, Inc.), and 1% SDS. The
hybridization solution contained 50% formamide, 5X SSC, 10X Denhardt’s
solution, 20 mM sodium phosphate buffer (pH 6.0), 100 ug/ml of denatured
salmon sperm DNA, 200 ug/ml torula yeast RNA, 10% dextran sulfate, 0.5%
SDS, and 10 X 106 cpm/10 ml of hybridization solution of the heat denatured
P-labeled probe.
The prehybridization and hybridization solutions for the RNA probe
for type X collagen were identical to those described for the aggrecan probe,
except that the amount of SDS was increased to 2% SDS in the
prehybridization solution and 1% SDS in the hybridization solution.
After hybridization with the probe for aggrecan, the nylon membranes
were washed two times for 10 min each at room temperature in 2X SSC, 0.5%
SDS, followed by 2 additioral 10 min washes at 55C in 2X SSC, 0.5% SDS.
After hybridization with the RNA probe for type X collagen, the nylon
membranes were washed two times for 5 min each in 2X SSC, 0.5% SDS at
room temperature, three times for 15 min each in 1X SSC, 0.5% SDS at 60C,
and one time for 15 min in 0.1X SSC, 0.5% SDS at 55C.
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The relative levels of type X collagen and aggrecan mRNAs on the
filters were quantified using a phosphorimager (PhosphorImager SITM,
Molecular Dynamics).
Dot blot hybridization, The dot blot hybridization technique, using
normalization to polyA/ RNA, was also used for quantitative analysis of
changes in amounts of mRNAs for type X collagen and aggrecan core protein.
This technique is more quantitative than Northern blot analysis in that it is
not as sensitive to small variations in intactness of the RNA and in that the
amounts are easily normalized to total poly A/ RNA.
Total RNA preparations were heated at 65C for 15 min in the presence
of 7.4% formaldehyde and 6X SSC. Aliquots were diluted with 15X SSC, and
spotted onto nitrocellulose filter paper (Schleicher and Schuell, Inc.). The
blots were baked at 80C in a vacuum oven for 90 min (White and Bancroft,
1982; Costanzi and Gillespie, 1987). Measurement of poly A/ RNA was done
using 32p-labeled oligo (dT)20 (Harley, 1987). Filters were pre-hybridized in 5X
SSC for 1 hour, and approximately 10 X 106 cpm of labeled oligo(dT)20 probe
per 130 cm2 filter was added to the hybridization solution containing 5X SSC,
5X Denhardt’s solution, 0.01 M Na2HPOa, and 0.001 M Na4P207 (Harley, 1987).
Hybridization was done at room temperature for 3 hours. Filters were then
washed at room temperature three times for 15 min each in 2X SSC and 0.1%
SDS. The relative levels of poly A/ RNA on the filters were quantitated by
scanning the dots on the autoradiograms in a phosphorimager.
Hybridization of labeled oligo (dT)20 to filter-bound poly A/ RNA was used to
normalize the amount of aggrecan core protein mRNA to total poly A/ RNA.
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A subsequent identical filter was prepared for hybridization with a 32p-labeled
probe for type X mRNA. The amount of type X collagen mRNA was also
normalized to total poly A/ RNA.
The prehybridization and hybridization solutions for the aggrecan probe
were identical to those described for the aggrecan probe in "IIIE. Northern
blot hybridization" except that the Denhardt’s solution was reduced from 10X
to 5X and no SDS was added.
The prehybridization and hybridization solutions for the RNA probe
for type X collagen were identical to those described for the aggrecan probe,
except for the addition of 2% SDS to the prehybridization solution and 1%
SDS to the hybridization solution.
Post-hybridization washings were performed as described under "IIIE.
Northern blot hybridization", and the relative levels of type X collagen and
aggrecan mRNAs on the filters were quantified using a phosphorimager.
V. RESULTS
Expression of hypertrophic-associated traits by Meckelian chondrocytes
in long term monolayer cultures
The first set of experiments was designed to examine the behavior of
chick Meckelian chondrocytes in long term monolayer culture conditions.
Previous studies had indicated that long term monolayer cultures provide a
permissive condition for chondrocyte maturation and induce cell
hypertrophy in mesodermally-derived permanent cartilages.
1. Cell morphology
Meckelian chondrocytes were isolated from 12-day old chick embryos
and plated on tissue culture dishes as described in Materials and Methods.
The changes in the cell morphology and cell size of Meckelian chondrocytes
in long term monolayer cultures were examined and compared at various
time intervals during the culture period using phase micrographs of live
cultures.
Examination of phase micrographs of live chondrocytes revealed that
after plating in primary cultures, most of the cells loosely attach to the tissue
culture dishes for the first 2-3 days. Twelve to twenty-four hours after initial
plating, the cells were round and loosely attached (Figure 1A), with an
average diameter of 7.5 + 2.3 tm (Table 1). By 7 days in primary culture, the
cells had increased in number (see below), and most of them detached from
the substrate, forming a homogenous population of suspended or floating
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cells. This unusual property of the chondrocytes was used to ensure their
separation from possible contaminating fibroblasts which strongly adhere to
the plastic substrate. Figure 1B shows the population of floating chondrocytes
after seven days in primary culture. The contaminating fibroblasts were left
behind at the time of subculturing. At this time, the average diameter of the
floating cells had increased to 18 + 3.2 m (Table 1). Floating Meckelian
chondrocytes were harvested from the media of day 7 primary cultures and
subcultured in the presence of a low concentration of hyaluronidase to induce
attachment. After 2-3 days in secondary cultures, mixed populations of
attached and floating chondrocytes formed (Figures 1C-1E). The attached
chondrocytes had a characteristic flattened polygonal morphology, and the
floating chondrocytes maintained a rounded morphology. Both types of
chondrocytes proliferated and were subcultured at weekly intervals in the
presence of a low concentration of hyaluronidase for an additional three
weeks. Microscopic examination revealed that during the three weeks in
secondary cultures, most, but not all, of the chondrocytes attached to the
culture dish (Fig. 1E).
There was an increase in size from the floating cells in primary
cultures to the attached cells in secondary cultures (Table 1). However, during
the time in secondary culture, the attached and floating chondrocytes
respectively did not increas6 significantly in size (Table 1).
2. Cell proliferation
The proliferative activity of the Meckelian chondrocytes at various
time intervals was examined using a hemocytometer. To determine the cell
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number, the entire cell population was recovered by enzymatic digestion at
weekly intervals and cell numbers were determined and compared to the
total number of cells at the start of culture.
The chondrocytes continued to proliferate over time in monolayer
culture. Figure 2 shows that the rates of proliferation increased over time in
culture.
3. Alkaline phosphatase activity
Previous studies have shown that chondrocyte hypertrophy is
associated with an induction of APase activity, an enzyme associated with
chondrocyte maturation.
The changes in APase activity associated with the cell layer in cultured
Meckelian chondrocytes were examined at different time intervals as
indicated in Materials and Methods using p-nitrophenol as a substrate. Low
but detectable levels of enzyme activity were present in 1-day old primary
cultures. The levels of APase activity increased approximately 60% in 7-day
old primary cultures (Figure 3). There were further increases in the APase
activity over time in secondary cultures (Figure 3). The most marked increase
occurred between 7 and 14 tays in secondary culture.
4. Relative expression of mRNAs for type X collagen and aggrecan core
protein
Previous studies have provided evidence for decreases in the rates of
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synthesis of type II collagen and aggrecan, the two major components of
cartilage ECM, during maturation of chondrocytes. In addition, it has been
clearly demonstrated that chondrocyte hypertrophy is associated with both
increases in APase activity and the appearance of a unique type of collagen,
type X collagen.
As the next step in determining the possibility of hypertrophy in
Meckelian chondrocytes in long term monolayer cultures, the relative
changes in mRNA for type X collagen were examined using Northern blot
and dot blot hybridization analysis. Total RNA was isolated from cultured
Meckelian chondrocytes at the various timepoints and processed for
Northern blot or dot blot hybridization analysis. For comparison, the levels
of mRNA for aggrecan core protein were also determined.
Northern analysis showed a single mRNA for aggrecan core protein of
8.1 kb in the total RNA extracted at various times from cultured Meckelian
chondrocytes (Figure 4). The size of the RNA in our study is consistent with
previous results (Sai et al., 1986). Dot blot and Northern blot analysis
indicated that aggrecan core protein mRNA was present in cultured
chondrocytes as early as one day in primary culture. The level of aggrecan
core protein mRNA increased approximately two and a half times and
reached its highest level during the 7 days in primary culture (Figure 5).
There were progressive decreases in the level of aggrecan core protein mRNA
over the subsequent fourteen days in secondary culture. There were no
significant changes in the levels of aggrecan core protein mRNA between 14
and 21 days in secondary culture. By the third week in secondary culture, the
level of aggrecan core protein was approximately one third (31%) of that seen
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at 7 days in primary culture (Figure 5).
In contrast to the aggrecan core protein mRNA, no detectable levels of
type X collagen mRNA were present in the one day old cultures. This mRNA
of about 2.5 kb (Figure 4)was first detected at low levels in RNA extracted
from cells after seven days in primary culture (Figure 6). The size of the RNA
in our study is consistent with previous results (Lu Valle et al., 1988).
During the subsequent 14 days in secondary culture, as levels of
aggrecan core protein mRNA decreased, there was a continuous and
progressive increase in type X collagen mRNA levels (Figure 6). The relative
levels of type X collagen mRNA did not change significantly between 14 and
21 days in secondary culture (Figure 6).
go Effects of AA on the expression of hypertrophic-associated traits by
Meckelian chondrocytes in vitro
Previous studies had indicated that environmental factors and
culturing conditions alter chondrocyte phenotype and promote cell
hypertrophy. Supplementation of the nutrient media with AA had been
shown to enhance the expression of the hypertrophic phenotype in chick
chondrocytes from the cephalic portion of the sternum (Leboy et al., 1989),
tibia (Habuchi et al., 1985), and vertebra (Gerstenfeld and Landis, 1991).
These studies demonstrated elevated levels of APase activity and type X
collagen synthesis (10-20 fold) in cultures treated with 50 ug/ml of AA as
compared to control untreated cultures (Leboy et al., 1989). In addition,
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recent studies indicate that chick mandibular ectomesenchyme can also be
induced to express hypertrophic-associated traits when treated with AA
(Ekanayake and Hall, 1994; Gluhak et al., 1996).
The second set of experiments was designed to examine the effects of
exogenous AA on the behavior of cultured Meckelian chondrocytes.
In these experiments, increasing concentrations of AA were added to
the secondary cultures according to the protocol by Leboy et al., 1989. After 1
day, secondary cultures received 10 ug/ml of AA. The AA concentration was
increased to 25 ug/ml three days later. Fresh AA was added to the cultures
daily (Leboy et al., 1989).
1. Cell morphology
The effects of AA on the cell morphology of Meckelian chondrocytes
over time in long term monolayer cultures were examined and compared to
the control untreated cultures at the various time intervals using phase
micrographs of living chondrocytes.
Within 24 hours after the addition of AA, the cells began to aggregate
in clusters. The addition f AA appeared to enhance cell attachment. The
cells treated with AA attached to the dish more quickly than the control cells,
and there were fewer floating cells. Over time in secondary culture, with
further cell attachment, the clusters of cells began to resemble cartilage
nodules. Figures 7A and 7B show examples of clusters of chondrocytes
treated with increasing concentrations of AA after one week (Figure 7A) and
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two weeks (Figure 7B) in secondary culture.
Similar to the control untreated cultures, there was an increase in size
from the floating cells in primary cultures to the attached cells in secondary
cultures (Table 1). However, during the time in secondary culture, neither
the attached nor the floating chondrocytes increased significantly in size
(Table 1).
2. Cell proliferation
The AA-treated chondrocytes continued to proliferate over time in
monolayer culture (Figure 2). The proliferation rates of the chondrocytes
treated with AA were lower than those of the control untreated cultures
(Figure 2).
3. Alkaline phosphatase activity
Previous studies have shown that the addition of AA can enhance the
expression of the hypertrophic-associated traits, and induce an increase in the
levels of APase activity in mesodermally-derived permanent chick
chondrocytes (Leboy et al., 1989; Habuchi et al., 1985; Gerstenfeld and Landis,
1991).
APase activity increased progressively over the 14 days in AA-treated
secondary culture, as it had in the control cultures. At 14 days in secondary
culture, the APase activity of AA-treated cultures was approximately nine
times higher than that of the untreated cultures (Figure 8). There was a
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decrease in APase activity (Figure 8) by 21 days in secondary cultures.
However, APase activity at this timepoint was still approximately four times
higher than that of the untreated cultures. Therefore, the addition of AA to
secondary cultures induced an increase in APase activity relative to that of the
control cultures (Figure 8).
4. Relative expression of mRNAs for type X collagen and aggrecan core
protein
The temporal expression of aggrecan core protein mRNA in the AA-
treated cultures was similar to that of the control untreated cultures. Similar
to the control cultures, aggrecan core protein mRNA was present in cultured
chondrocytes as early as one day in primary culture, and increased during the
7 days in primary culture (Figure 9). There were progressive decreases in the
level of aggrecan core protein mRNA over the subsequent 14 days in the AA-
treated secondary cultures, similar to the decrease seen in the control cultures
(Figure 9). By the third week in secondary culture, the level of aggrecan core
protein was approximately one fourth (27%) of that seen at 7 days in primary
culture, lower than the decrease to one third (31%) seen in the control
untreated cultures.
The temporal expression of type X collagen mRNA in the AA-treated
cultures was also similar to that of the control cultures. Similar to the control
untreated cultures, in AA-treated cultures, there were progressive increases
in the relative levels of type X collagen mRNA during the 14 days in
secondary culture (Figure 10). Levels of mRNA for type X collagen in the AA-
treated secondary cultures were slightly higher than those of the untreated
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cultures throughout the time in secondary culture (Figure 10). Similar to the
untreated cultures, in the AA-treated cultures, levels of mRNA for type X
collagen did not change significantly between 14 and 21 days in secondary
culture (Figure 10).
VI. DISCUSSION
Avian Meckel’s cartilage is one of the cartilages that is present
throughout postnatal life and does not undergo endochondral ossification.
Therefore, the behavior and developmental fate of avian Meckelian
chondrocytes differ from other chondrocytes that undergo maturation and
hypertrophy. The mechanisms that regulate the different fates of chondrocytes
in permanent cartilages and cartilages that undergo maturation and
hypertrophy are not well understood.
This study investigated the possibility that the permanent chondrocytes
from chick Meckel’s cartilage could be induced to mature and undergo
hypertrophy when removed from their in vivo environment and placed into
a permissive environment in vitro. The ability of the Meckelian chondrocytes
to hypertrophy was studied by examining the changes in hypertrophic-
associated traits, including cell morphology, cell proliferation, APase activity,
and changes in the expression of mRNAs for type X collagen and aggrecan core
protein in Meckelian chondrocytes placed in long term monolayer cultures.
The changes over time in APase activity and in the relative levels of mRNAs
for type X collagen and aggrecan core protein in cultured Meckelian
chondrocytes were correlated with the changes in cell morphology, cell size,
and proliferative activity of the cells.
The results of this study showed that a subpopulation of Meckelian
chondrocytes isolated from 12 day old chick embryos underwent cell
hypertrophy, expressed elevated levels of APase activity, and initiated type X
collagen synthesis with time in long term monolayer cultures.
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Our results showed that during the 7 days in primary cultures, the
initially round, small, immature Meckelian chondrocytes engaged in active
proliferation and increased their size and average diameter. Our Northern
and dot blot hybridizations also showed increases in the expression of mRNA
for aggrecan core protein in 7 day old primary cultures. In addition, our
Northern blot analysis revealed that the immature chondrocytes contained
no detectable levels of the 2.5 kb type X collagen mRNA. The increase in size
of the chondrocytes in primary monolayer culture from 7.5 tm to 18 tm was
associated with the induction of type X collagen synthesis. Low but detectable
levels of mRNA for type X collagen were first detected at seven days in
primary culture. Our APase activity assays indicated that the increases in cell
size, cell proliferation, and changes in gene expression were also accompanied
by increases in APase activity during the 7 days in primary cultures.
Upon subculturing of the pure population of floating chondrocytes
after 7 days in primary culture, and during the next 14 days in secondary
culture, there were further increases in APase activity. The increase in APase
activity seen in our control cultures was accompanied by increasing levels of
type X collagen synthesis and decreasing levels of aggrecan core protein.
Type X is only exp:essed by hypertrophic chondrocytes undergoing
endochondral ossification (Schmid and Linsenmayer, 1983, 1985a, 1985b;
Gibson and Flint, 1985; Grant et al., 1985; Linsenmayer et al., 1986). Chung et
al.’s (1995) study with rat Meckel’s cartilage demonstrated that type X collagen
synthesis was restricted to the portion that undergoes endochondral
ossification to give rise to the malleus and incus. Chondrocytes from the
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portion of Meckel’s cartilage that transformed to fibroblasts did not express
type X collagen (Chung et al., 1995). Our Northern blot and dot blot
hybridization analyses demonstrated increases in the levels of type X collagen
during the 14 days in secondary cultures. The increases in the levels of
mRNA for type X collagen during the 14 days in secondary cultures correlated
with decreasing levels of mRNA for aggrecan core protein. However, there
were no significant changes between the type X collagen mRNA levels
between 14 and 21 days in secondary culture. This may suggest that some of
the chondrocytes were beginning to lose their phenotype. Some studies have
reported that chondrocytes maintained in culture for extended periods of
time gradually lose their phenotype, and dedifferentiate into fibroblast-like
cells (Capasso et al., 1982; Castagnola et al., 1987; Muir, 1995).
Our observations are consistent with observations on mesodermally-
derived cartilages and suggest that Meckelian chondrocytes, like other
permanent chondrocytes, appear to have the ability to undergo maturation
and hypertrophy in response to favorable in vitro culture conditions.
In vivo and in vitro studies indicated that during the process of
endochondral ossification, as chondrocytes mature and become hypertrophic,
they undergo a complex process of maturation that involves changes in cell
proliferation, cell shape dnd size, and gene expression. Previous studies
showed that maturation is associated with a five- to ten-time increase in cell
volume (Buckwalter et al., 1986; Hunziker et al., 1987). This increase in size is
accompanied by an increase in APase activity (Fell and Robison, 1934, 1929;
Ali et al., 1970) and induction of type X collagen synthesis (Gibson et al., 1982;
Schmid and Conrad, 1982a; Schmid and Linsenmayer, 1987).
However, recent in vitro studies have indicated that type X collagen
synthesis may occur independently of increases in cell size (Pacifici et al.,
1991a; Ekanayake et al., 1994). Pacifici et al. (1991a) noted that there was no
difference in size between the articular chondrocytes which synthesized type
X collagen and those that did not. Furthermore, in Ekanayake et al.’s (1994)
study with chick mandibular ectomesenchyme, both small cells and large,
hypertrophic cells synthesized type X collagen.
Fell and Robison (1929) were among the first to notice that chondrocyte
hypertrophy was associated with the synthesis of APase. It is now known that
all mineralizing tissues demonstrate high levels of APase activity (Wuthier,
1982). Previous studies have indicated that during maturation and
hypertrophy, the increases in type X collagen synthesis and APase activity are
accompanied by decreases in synthesis of the major components of the
cartilage ECM: type II collagen and aggrecan (Poole, 1991). These qualitative
and quantitative changes of the ECM are thought to facilitate subsequent
mineralization of the matrix (Schmid and Linsenmayer, 1987).
In addition, in vitro studies revealed that, when chondrocytes from
other permanent cartilages are placed in a variety of permissive
environments, they under’go maturation and hypertrophy in vitro. The
caudal region of the chick embryo sternum remains cartilaginous during
early post-natal life, and undergoes endochondral ossification only in the
adult chicken (Gibson and Flint, 1985). However, when chondrocytes isolated
from this region were grown in suspension (Castagnola et al., 1987) or within
collagen gels (Solursh et al., 1986), they proliferated and progressively
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increased in size. This increase in size in vitro was accompanied by the
initiation and further increase in the synthesis of type X collagen (Solursh et
al, 1986; Castagnola et al., 1987). Furthermore, when Pacifici et al. (1991b) grew
cells from this region in monolayer culture supplemented with retinoic acid,
they demonstrated a correlating increase in APase activity as well. These
processes of maturation in vitro of the permanent chondrocytes from the
caudal region of the chick sternum were similar to those that occur in vivo.
Our observations (increase in cell size, increase in APase activity,
increase in type X collagen synthesis, and decrease in aggrecan synthesis)
together suggest that a subpopulation of the avian Meckelian chondrocytes
also have the ability to express hypertrophic-associated traits when removed
from their in vivo environment and placed into a permissive environment
in vitro.
The observations of our study are consistent with previous results in
many respects. As our avian Meckelian chondrocytes proliferated in
monolayer culture and increased in size, their morphological changes were
accompanied by increasing levels of APase activity, and the initiation and
increase in type X collagen mRNA synthesis. The expression of hypertrophic-
associated traits was correlated with a decrease in the synthesis of aggrecan
core protein mRNA.
Permanent chondrocytes isolated from adult chicken tibial articular
cartilage (Pacifici et al., 1991a) and from the caudal region of the chick embryo
sternum (Castagnola et al., 1987) underwent similar changes when grown in
long-term suspension cultures. These chondrocytes proliferated, increased in
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size, and initiated the synthesis of type X collagen. Whether these changes
were accompanied by an increase in APase activity or a decrease in aggrecan
core protein synthesis was not reported in either study.
Chondrocytes from the caudal portion of the chick sternum grown in
monolayer culture also underwent a similar process of maturation in vitro
when supplemented with retinoic acid (Pacifici et al., 1991b). This study
reported that treatment with physiological doses of retinoic acid (10-35 nM)
resulted in increased APase activity and type X collagen synthesis.
Interestingly, they found no difference in size between chondrocytes which
were producing type X collagen and those that were not, suggesting that the
initiation of type X collagen synthesis is independent of cell hypertrophy. In
our study, the greatest increase in cell size was correlated in time with the
induction of type X collagen synthesis. However, we did not determine
which of the cells in culture were producing type X collagen and which were
not.
The processes of maturation and hypertrophy of chondrocytes from the
cephalic portion of the chick sternum grown in monolayer culture also
involved increases in the average cell size (Leboy et al., 1989). Similar to our
observations, the increase in size in vitro was also accompanied by increases
in APase activity, the initiation and subsequent increase in the synthesis of
type X collagen mRNA, and a decrease in the synthesis of aggrecan core
protein mRNA. The increase in APase activity, increase in type X collagen
mRNA synthesis, and decrease in aggrecan core protein mRNA synthesis
were generally correlated in time, as they were in our study.
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However, our results regarding the proliferative activity of Meckelian
chondrocytes during maturation and hypertrophy are different from previous
observations. In vivo, as chondrocytes mature into hypertrophic cells, their
proliferation rate decreases (Muir, 1995). The maturation-associated
expression of the type X collagen gene is restricted to hypertrophic, non-
proliferating cells (Muir, 1995).
In vitro studies have suggested that a decrease in proliferation may be
necessary for maturation to occur (Adams et al., 1991). Adams et al.’s (1991)
study showed that a decrease in proliferation was associated with an increase
in the expression of maturation-associated traits. Chick embryo vertebral
chondrocytes were grown in monolayer culture and then switched to
suspension culture. The chondrocytes changed in shape from flat to round
and decreased their proliferation rate, mimicking the in vivo situation. This
decrease in proliferation was accompanied by an increase in type X collagen
gene expression (Adams et al., 1991).
The idea that decreased proliferation may be necessary for maturation
to occur was further supported by Iwamoto et al.’s (1993b) study. This study
with the chick embryo sternum showed a relationship between cellular
proliferation and expression of the type X collagen gene. In this study,
proliferating cells did not express the type X collagen gene. Proliferating cells
also contained a high level of the transcript for the c-myc gene, a gene
thought to be involved in the regulation of cell proliferation (Kelly et al.,
1983). Transcripts for the c-myc gene were not detected in hypertrophic, non-
proliferating cells. When cultured chondrocytes were infected with the c-myc
gene by retroviral vectors, the chondrocytes remained in a proliferative state,
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failed to mature into hypertrophic cells, and did not express the type X
collagen gene (Iwamoto, et al., 1993b). This study suggested that the c-myc
gene is associated with repressing the expression of the type X collagen gene.
A decrease in the c-myc gene expression (and thus, a decrease in proliferation)
may be necessary for the type X collagen gene to be expressed (Iwamoto, et al.,
1993b).
In contrast to the in vivo and in vitro observations that maturation is
accompanied by a decrease in proliferation, our data indicated that the avian
Meckelian chondrocytes continued to proliferate over time in monolayer
culture. This inconsistency could be due to the fact that only a fraction of the
cells in our culture underwent maturation, while the remaining cells
continued to be in a proliferative, and perhaps non-hypertrophic, state.
The presence of distinct cell subpopulations within chondrocyte
cultures has been previously reported. The presence of two cell populations
within cultures of chick tibial chondrocytes" floater cells, and epithelial-like,
polygonal, attached cells, was reported by Capasso et al. (1982). Both types of
cells synthesized type II collagen and cartilage-specific proteins. When the
floater cells were transferred to new dishes, some attached, assuming the
polygonal morphology, divided, and formed colonies that gave rise to new
floater cells.
In addition, further evidence of the heterogeneity of chondrocyte
cultures comes from Pacifici et al. (1991a)’s observation that chondrocyte
maturation is an asynchronous process. They noted that only a fraction of the
articular and sternal chondrocytes used in their studies had activated type X
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collagen synthesis by 5 weeks in culture, similar to the observations made by
Solursh et al. (1986). It was suggested that the chondrocyte populations may
be heterogeneous, containing some cells that have the ability to mature, and
others that can not mature, under the culture conditions used in the study. It
was also suggested that a longer culture time may be required for the entire
cell population to mature (Pacifici et al., 1991a).
Our results clearly indicate that at least a subpopulation of
chondrocytes underwent maturation in our cultures, Our study did not
distinguish between the round, floating cells and the flat, attached, polygonal
cells that were present in varying proportions throughout secondary cultures.
It is possible that these two groups of cells represent two distinct cell
populations: one that is undergoing maturation, and one that may not be
undergoing maturation. Further experiments are needed to determine what
percentage of the cells in our study underwent maturation.
This study also examined the effects of the addition of exogenous AA
on the behavior of Meckelian chondrocytes in long term monolayer cultures.
Our observations with the addition of exogenous AA appear to suggest that
AA may enhance the expression of type X collagen mRNA and APase activity
of Meckelian chondrocytes.
AA has been shown to enhance chondrogenesis and promote
hypertrophy in mesodermally-derived chondrocytes from the cephalic region
of the sternum (Leboy et al., 1989), vertebrae (Gerstenfeld and Landis, 1991),
and the growth plate (Wu et al., 1989). Although AA’s exact mechanisms of
action are not known, it is probable that AA’s effects on chondrocyte
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hypertrophy are mediated by its effects on collagen biosynthesis. AA plays an
essential role in collagen biosynthesis by promoting proline and lysine
hydroxylation, which results in the formation of a more stable secreted triple
helical collagen (Kivirikko and Myllyla, 1987). The AA-induced promotion of
hypertrophy has been shown to be associated with increased levels of APase
activity and type X collagen expression (Leboy et al., 1989; Shapiro et al., 1991).
In addition, more recent studies have suggested that the addition of
AA may be able to induce hypertrophy and maturation in Meckelian
chondrocytes in vitro (Ekanayake and Hall, 1994; Gluhak et al., 1996).
Previous studies had suggested that avian Meckelian chondrocytes lacked the
ability to hypertrophy in vitro (Kavumpurath and Hall, 1990). However,
recent studies suggested that Meckelian chondrocytes could undergo
hypertrophy in the presence of AA with time in culture (Ekanayake and Hall,
1994; Gluhak et al., 1996). However, these studies used mixed cultures from
an early mandible. Hypertrophy of differentiated Meckel’s cartilage in the
presence and absence of AA had not been previously examined.
Unlike the control cultures in the two studies mentioned above
(Ekanayake and Hall, 1994; Gluhak et al., 1996), our control cultures, not
treated with AA, demonstrated APase activity and expressed type X collagen.
Our observations suggest that a subpopulation of avian Meckelian
chondrocytes isolated from fully differentiated Meckel’s cartilage can undergo
hypertrophy in vitro in long term monolayer cultures in the absence of AA.
Our examination of cell morphology revealed no significant changes in
the proliferative activity or cell volume of the Meckelian chondrocytes grown
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in the presence or absence of AA. This is consistent with Leboy et al.’s 1989
findings. In vitro, when chondrocytes from the cephalic portion of the
sternum were grown in monolayer culture, the average cell size increased
with time in culture, both in the presence and absence of AA (Leboy et al.,
1989).
On the other hand, in the presence of AA, we observed a significant
increase in the levels of APase activity in the AA-treated cultures as
compared to the controls. Avian Meckelian chondrocytes grown in the
presence of AA demonstrated levels of APase activity up to nine times higher
than that of the control cultures. These results are consistent with the
findings of previous studies (Leboy et al., 1989; Shapiro et al., 1991). Earlier
studies had demonstrated the ascorbic-acid mediated enhancement of
hypertrophy in mesodermally-derived chondrocytes in vitro (Leboy et al.,
1989; Shapiro et al., 1991). After 18 days in secondary culture, tibial
chondrocytes grown in the presence of 40 ug/ml AA showed an APase
activity three times that of the untreated cells (Shapiro et al., 1991). After nine
days in secondary culture, chondrocytes from the cephalic portion of the chick
sternum grown in the presence of 50 ug/ml AA showed an APase activity 15-
20 times that of the untreated cells (Leboy et al., 1989).
Differences in the magnitude of the AA-induced increase in APase
activity between our study and Leboy et al.’s 1989 study might be accounted for
by the following differences between the two studies:
The AA levels added to secondary cultures in Leboy et al.’s 1989 study
were higher than those used in our study. 10 ug/ml of AA was added after
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one day in secondary culture. AA levels ere increased o 25 ug/ml a day G
and further increased to 50 ug/ml at day 7 (Leboy et al., 1989). In our study, 10
ug/ml of AA was added after one day in secondary culture. AA levels were
increased to 25 ug/ml at day 4, and maintained at 25 ug/ml thereafter.
However, Shapiro et al. (1991), using 40 ug/ml of AA, found only a three-fold
increase in APase activity in tibial chondrocytes treated with AA.
In addition, our study measured only the APase associated with the cell
layer. APase is found in the plasma membranes of chondrocytes and in
matrix vesicles in the ECM (Ali et al., 1970; Matsuzawa and Anderson, 1971;
Viiininen and Korhonen, 1979; Hsu et al., 1985; de Bernard et al., 1986). Leboy
et al. (1989) measured the APase activity of the cell layer and the activity of the
attached matrix, separately and together. They found that 65% of the APase
was associated with the cells; the rest was contained in the matrix. However,
Shapiro et al. (1991), using the same measurement technique as Leboy et al.
(1989), found only a three-fold increase in APase activity in tibial
chondrocytes treated with AA.
Therefore, the differences in the magnitudes of the AA-induced
increases may be due to innate differences between sternal, tibial, and
Meckelian chondrocytes.
Our observations show that the treatment of avian Meckelian
chondrocytes with AA resulted in slightly higher levels of type X collagen
relative to those seen in the control cultures. In Leboy et al.’s 1989 study,
treatment of chick cephalic sternal chondrocytes with AA increased type X
collagen synthesis by 15-20 times. In our study, while treatment with AA did
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increase type X collagen mRNA levels relative to untreated cultures, the
magnitude of the increase was not as great as in Leboy et al.’s 1989 study.
Reasons for this difference in the magnitude of increase could be the
innate differences between sternal chondrocytes and Meckelian chondrocytes,
or the differences in the amount of AA added to the cultures. The
observation that type X collagen mRNA levels did not change significantly
between 14 and 21 days in secondary culture in both the AA-treated and
untreated cultures could not be compared to Leboy et al.’s 1989 study; their
cultures were not studied beyond 11 days in secondary culture. The
observation that type X mRNA levels did not continue to increase between 14
and 21 days in secondary cultures, accompanied by the decrease in APase
activity levels by 21 days in secondary culture, could indicate that some of the
cells had lost the differentiated chondrocyte phenotype.
Increases in levels of mRNA for type X collagen in secondary cultures
corresponded with decreasing levels of mRNA for aggrecan core protein.
This decrease in aggrecan core protein during 14 days in secondary culture
was consistently seen in both AA-treated and untreated cultures.
In summary, these results suggest that Meckelian chondrocytes have
the ability to mature in a permissive environment. These observations raise
the possibility that the microenvironment in vivo may inhibit the
endochondral ossification of Meckel’s cartilage. Alternatively, it is also
possible that the microenvironment in vivo lacks factors that are required for
chondrocyte maturation.
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Lu Valle et al. (1993) reported that the type X collagen gene contains
multiple negative regulatory elements that restrict transcription of this gene
to hypertrophic chondrocytes undergoing endochondral ossification.
Fragments of DNA located upstream from the type X collagen promoter
region were found to act additively to suppress promoter activity in
immature, non-hypertrophic chondrocytes, but had no significant effect on
promoter activity in hypertrophic chondrocytes (Lu Valle et al., 1993). In
vivo, these multiple negative regulatory elements may act to prevent the
expression of type X collagen in avian Meckelian chondrocytes.
VII. CONCLUSIONS
Our studies on the behavior of avian Meckelian chondrocytes in long
term monolayer cultures indicated that:
1) Average cell size and cell number increased over time in culture, both in
the presence and absence of AA.
2) Alkaline phosphatase activity increased over time in culture. Treatment
with AA induced higher levels of alkaline phosphatase activity.
3) The synthesis of type X collagen was induced after seven days and
increased over time in culture. Treatment with AA resulted in slightly
higher levels of type X collagen.
4) The expression of hypertrophic-associated traits over time was correlated
with a decrease in the expression of aggrecan core protein mRNA, both in
control and AA-treated cultures.
Therefore, these observations suggest that a subpopulation of avian
Meckelian chondrocytes can undergo hypertrophy and maturation in vitro in
long term monolayer cultures in the presence or absence of AA, as evidenced
by the expression of the following hypertrophic-associated traits: 1) increase in
cell size, 2) increase in alkaline phosphatase activity, and 3) synthesis of type X
collagen.
Previous studies had suggested that avian Meckelian chondrocytes
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lacked the ability to hypertrophy in vitro. Our study suggests that
chondrocytes from differentiated avian Meckel’s cartilage do possess the
intrinsic ability to undergo hypertrophy and maturation in vitro in
permissive culture conditions.
Table 1. Changes in cell size (tm) in Meckelian chondrocytes placed in
control untreated and ascorbic acid-treated monolayer cultures.
Primary Cultures
1day 7.5 + 2.3
7days 18 + 3.2
Secondary Cultures Floaters
Controls AA-treated
7days 18 + 2.2 18 + 2.5
14 days 19 + 5.1 Few floaters present
21 days 17 + 1.7 Few floaters present
Secondary Cultures Attached
Controls AA-treated
7days 27 + 6.7 26 + 2.6
14days 29 + 7.3 28 + 2.0
21 days 31 + 5.6 28 + 3.0
Figure 1. Changes in cell morphology and cell size in Meckelian chondrocytes
placed in long term monolayer cultures.
Phase micrographs of one day old (A) and seven day old (B) primary cultures
of Meckelian chondrocytes" Note the small, round chondrocytes with an
average diameter of 7.5 + 2.3 tm in one day old primary cultures (A). Also
note the increase in the size to 18 + 3.2 tm of the round, floating
chondrocytes after 7 days in primary cultures (B).
Meckelian chondrocytes after seven (C), fourteen (D) and twenty-one (E) days
in secondary culture: Note that with further maturation in secondary
culture, the cells appeared as a mixed population of round, floating cells
(indicated by small arrowhead) and fiat, attached polygonal cells (indicated by
large arrowhead). By 14 21 days in secondary culture, although most of the
cells were attached and had a flat, polygonal morphology, note that round
chondrocytes are also present (D-E).
A X200
B E X400
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Figure 2. Comparison of proliferation rates in control untreated and ascorbic
acid-treated cultures of Meckelian chondrocytes.
Proliferation rates were calculated as the percentage increase in cell number
per dish during the weekly intervals. Note that proliferation rates increased
over time in long term monolayer cultures. Note that the proliferation rates
for the ascorbic acid-treated cultures were lower than those of the control
untreated cultures. Values are means of 1-3 determinations + standard error.
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Figure 3. Alkaline phosphatase activity in control cultures.
Alkaline phosphatase activity associated with the cell layer in cultured
Meckelian chondrocytes was examined over time as described under
"Materials and Methods" using p-nitrophenol as a substrate. Alkaline
phosphatase activity associated with the cell layer was measured in nmol of p-
nitrophenol product produced per minute per mg of protein. Values are
means of 3 determinations + standard error.
Note the low but detectable levels of alkaline phosphatase activity in the one
day old primary cultures. Note that alkaline phosphatase activity
progressively increased over time in culture, with the greatest increase
occurring between 7 and 14 days in secondary culture.
61 day 7 days 7 days 14 days 21 days
Primary Secondary
Figure 4. Northern blot hybridization analysis of aggrecan core protein
mRNA and type X collagen mRNA expression in control untreated cultures
of Meckelian chondrocytes in long term monolayer cultures.
Approximately 10 tg of total RNA was electrophoresed, transferred to a nylon
membrane, and hybridized with 5 x 106 cpm of ST-1 probe for aggrecan core
protein. The filter was exposed for 5 hours with intensifying screens at-70C.
An identical filter was hybridized with 5 x 106 cpm of 32p labeled RNA probe
for type X collagen.
screens at-70C.
The filter was exposed for 2 hours without intensifying
Lane 1 contains mRNA from a stage 36 chick mandible as a control. Lanes 2-4
contain mRNA from 1 day in primary culture, 7 days in primary culture, and
21 days in secondary culture. The size of the mRNA was estimated by
reference to RNA size markers (BRL) run in adjacent lanes.
Aggrecan core protein mRNA of 8.1 kb and type X collagen mRNA of about
2.5 kb was detected in the total RNA isolated at the various timepoints from
cultured avian Meckelian chondrocytes.
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Figure 5. Relative levels of aggrecan core protein mRNA in control untreated
cultures of Meckelian chondrocytes.
At each timepoint, approximately 5 ug of RNA was prepared for dot blot
hybridization analysis. Filters were hybridized with a 32p-labeled probe for
aggrecan core protein mRNA. The same filters were then hybridized with 10
x 106 cpm of labeled oligo (DT)20 to determine the amount of poly A+ RNA
present in different samples. The levels of mRNAs were quantified by
scanning the dots with a phosphorimager. Values are means of 4
determinations + SD.
Note that aggrecan core protein mRNA was present in cultured chondrocytes
as early as one day in primary culture, and reached its highest level during
the 7 days in primary culture. Progressive decreases in the level of aggrecan
core protein mRNA occurred over the subsequent 14 days in secondary
cultures. Note that there were not significant changes in the levels of
aggrecan core protein mRNA between 14 and 21 days in secondary culture.
Note that by 21 days in secondary cultures, the level of aggrecan core protein
mRNA had decreased to 31% of that seen in the 7 day old primary cultures.
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Figure 6. Relative levels of type X collagen mRNA in control untreated
cultures of Meckelian chondrocytes.
At each timepoint, approximately 5 ug of RNA was prepared for dot blot
hybridization analysis. Filters were hybridized with a 32p-labeled probe for
type X collagen mRNA. Identical filters were hybridized with 10 x 10a cpm of
labeled oligo (DT)20 to determine the amount of poly A+ RNA present in the
different samples. The levels of mRNAs were quantified by scanning the dots
with a phosphorimager. Values are means of 4 determinations + SD.
Note that no detectable levels of type X collagen mRNA were present in the
one day old cultures. Type X collagen mRNA was first detected at low levels
in the total RNA extracted from cells after seven days in primary culture.
During the subsequent 14 days in secondary culture, there was a continuous
increase in type X collagen mRNA levels. Note that the levels of type X
collagen mRNA did not change significantly between 14 and 21 days in
secondary culture.
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Figure 7. Changes in cell morphology over time in cultures of Meckelian
chondrocytes treated with ascorbic acid.
Phase micrographs of secondary cultures of Meckelian chondrocytes grown
for 7 (A), 14 (B), and 21 (C) days in the presence of ascorbic acid:
Note that the cells treated with ascorbic acid tended to aggregate in clusters
(A). Note that over time in secondary culture, with further cell attachment,
the clusters of cells began to resemble cartilage nodules (B). Note that the
ascorbic-acid treated cultures contained cells with both round (indicated by
small arrowhead)and polygonal (indicated by large arrowhead) morphology
after 14- 21 days in secondary culture (B-C).
A C X400.
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Figure 8. Comparison of alkaline phosphatase activity in control untreated
and ascorbic acid-treated cultures of Meckelian chondrocytes.
Alkaline phosphatase activity associated with the cell layer in cultured
Meckelian chondrocytes was examined over time as described under
"Materials and Methods" using p-nitrophenol as a substrate. Alkaline
phosphatase activity associated with the cell layer was measured in nmol of p-
nitrophenol product produced per minute per mg of protein. Control values
are means of 3 determinations + standard error. Ascorbic acid-treated values
are from one determination.
Note that ascorbic acid induced an increase in alkaline phosphatase activity in
the ascorbic acid-treated cultures relative to the control untreated cultures.
Note that by 14 days in secondary culture, alkaline phosphatase activity in the
ascorbic acid-treated cultures reached levels nine times higher than that of the
control untreated cultures. Note that alkaline phosphatase activity decreased
in the ascorbic acid-treated cultures by 21 days in secondary culture, yet
remained four times higher than that of the control untreated cultures.
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Figure 9. Comparison of the relative levels of mRNA for aggrecan core
protein in control untreated and ascorbic acid-treated cultures of Meckelian
chondrocytes.
At each timepoint, approximately 5 ug of RNA was prepared for dot blot
hybridization analysis. Filters were hybridized with a 32p-labeled probe for
aggrecan core protein mRNA. The same filters were then hybridized with 10
x 106 cpm of labeled oligo (DT)20 to determine the amount of poly A+ RNA
present in different samples. The levels of mRNAs were quantified by
scanning the dots with a phosphorimager. Control values are means of 4
determinations + SD. Ascorbic acid-treated values are means of 2
determinations + SD.
Note that the temporal expression of the aggrecan core protein mRNA in the
ascorbic acid-treated cultures was similar to that of the control untreated
cultures. Aggrecan core protein mRNA was present in one day old primary
cultures, reached its highest level during the 7 days in primary culture, and
progressively decreased over the subsequent 14 days in secondary cultures.
Note that there were not significant changes in the levels of aggrecan core
protein mRNA between 14 and 21 days in secondary culture, similar to the
control untreated cultures. Note that by 21 days in secondary cultures, the
level of aggrecan core protein mRNA in the ascorbic acid-treated cultures had
dropped to 27% of that seen in the 7 day old primary cultures, compared to
the 31% seen in the control untreated cultures.
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Figure 10. Comparison of the relative levels of mRNA for type X collagen in
control untreated and ascorbic acid-treated cultures of Meckelian
chondrocytes.
At each timepoint, approximately 5 ug of RNA was prepared for dot blot
hybridization analysis. Filters were hybridized with a 32p-labeled probe for
type X collagen mRNA. Identical filters were hybridized with 10 x 10a cpm of
labeled oligo (DT)20 to determine the amount of poly A+ RNA present in
different samples. The levels of mRNAs were quantified by scanning the dots
with a phosphorimager. Control values are means of 4 determinations + SD.
Ascorbic acid-treated values are means of 2 determinations + SD.
Note that the temporal expression of type X collagen mRNA in the ascorbic
acid-treated cultures was also similar to that of the control untreated cultures.
Note that there were progressive increases in the relative levels of type X
collagen mRNA during the 14 days in secondary culture. Note that the levels
of mRNA for type X collagen did not change significantly between 14 and 21
days in secondary culture in both ascorbic acid-treated and untreated cultures.
Note that, throughout the time in secondary culture, levels of type X collagen
mRNA in the ascorbic acid-treated cultures were slightly higher than those of
the untreated cultures.
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HYPERTROPHY OF AVIAN MECKELIAN
CHONDROCYTES IN VITRO
Irene Marie Fowell, D.D.S.
University of Connecticut, 1996
Most cartilages that appear during embryonic development undergo
endochondral ossification and are replaced by bone. However, there are a few
cartilages whose developmental fates appear to be different from other cartilages
in that they persist into adult life. The main body of avian Meckel’s cartilage, a
neural-crest derived cartilage, does not undergo endochondral ossification. The
mechanisms regulating developmental fates of chondrocytes are not well
understood. One possibility considered is that the fates of chondrocytes are
determined and regulated by micro-environmental factors. This study
investigated the possibility that the permanent chondrocytes from chick Meckel’s
cartilage could be induced to mature and undergo hypertrophy when removed
from their in vivo environment and placed into a permissive environment in
Irene Marie Fowell University of Connecticut, 1996
vitro. The ability of the Meckelian chondrocytes to hypertrophy was studied by
examining the changes in hypertrophic-associated traits, including cell
morphology, cell proliferation, alkaline phosphatase (APase) activity, and
changes in the expression of mRNAs for type X collagen and aggrecan core
protein in Meckelian chondrocytes placed in long term monolayer cultures in the
presence and absence of ascorbic acid. Chondrocytes isolated from the
midsection of Meckel’s cartilage rods of day 12 chick embryos were placed in
primary cultures. After 6 days, a pure population of floating chondrocytes was
collected from the culture media and maintained in monolayer until day 21.
Avian Meckelian chondrocytes in both control and ascorbic-acid treated cultures
proliferated and increased in size. These morphological changes were
accompanied by increasing APase activity, and the initiation and further increase
in type X collagen mRNA synthesis. The expression of hypertrophic-associated
traits was correlated with decreasing synthesis of aggrecan core protein mRNA
in both the control and ascorbic acid-treated cultures. In addition, the ascorbic-
acid treated cultures demonstrated increases in APase activity and slightly
higher levels of type X collagen mRNA synthesis as compared to control
cultures. Our results suggest that a subpopulation of avian Meckelian
chondrocytes do have the ability to undergo hypertrophy and maturation in vitro
and that there may be inhibitory factors in the in vivo microenvironment that
prevent endochondral ossification of Meckel’s cartilage in birds.
